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Abstract
Brachytherapy is a form of radiation treatment for cancer that involves the
placement of sealed radioactive sources inside or in close proximity to the tu-
mour in order to deliver radiation dose to the cancerous cells. Although the
growing use of imaging has improved the quality of treatment the patients re-
ceive, there are still challenges to overcome.
In cervical brachytherapy the radiation dose is delivered using an applicator.
The applicator position is used for treatment planning therefore misplacement
of the applicator could result in inaccurate treatment, increased levels of toxi-
city in healthy tissues and even punctures in the uterus during the insertion
process. During the insertion the applicator is not visible therefore the treat-
ment may be compromised. It was shown in previous studies that the appli-
cator displacement between each brachytherapy was greater than 1cm. The
main question to achieve applicator tracking was to examine if the electromag-
netic tracking system that is used to track the ultrasound probe during image
registration could be used to solve this issue. Through this thesis a tracking
system methodology was developed and its accuracy was measured in a trial
and in clinic. For the phantom trial the magnitude of error was measured to be
≈ 3mm and for the clinical evaluation of the tracking system at Royal Surrey
County hospital (RSCH) the magnitude of error was measured to be ≈ 5mm.
In prostate brachytherapy a computer tomography (CT) scan is performed to
the patient in order to aid the verification process but unfortunately the seeds
produce multiple artefacts that make the verification process difficult and some-
times impossible because the contour of the prostate is not clear therefore the
dosimetry results are inaccurate. A filter methodology was developed to ad-
dress that issue by performing exemplar image inpainting for the corrupted
portion of post prostate CT images. The filtered images were qualitatively com-
pared with a state of the art filter for reducing metal artefact. Additionally the
filter is currently being evaluated in a study where the aim is to measure the
inter-observer reliability of contouring the prostate in unfiltered and filtered in
post prostate brachytherapy CT scans. Two observers from the RSCH agreed
on contouring 11 patient dataset for this study. There are only preliminary
results for this study but they do not show any improvements in contouring
the prostate. The trial is still on-going therefore more data will show the actual
effect of the filter.
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Chapter 1
Introduction
1.1 Thesis Aim
The aim of this thesis is to identify imaging challenges in brachytherapy and
develop novel solutions for them. Brachytherapy is a form of radiation treat-
ment for cancer that involves the placement of sealed radioactive sources in-
side or in close proximity to the tumour in order to deliver radiation dose to the
cancerous cells. In most cases the radioactive sources, or seeds, are removed
after a certain amount of time when the desired dose is delivered. Usually
brachytherapy is invasive meaning the patient undergoes an operation. In
principle brachytherapy can achieve high dose deposition in the tumour while
sparing the surrounding healthy tissues. Currently brachytherapy treatment
is widely used for prostate, cervical, skin and breast cancer. Due to advance-
ments in technology a variety of image modalities are used in brachytherapy
the most common are magnetic resonance imaging (MRI), computed tomogra-
phy (CT), ultrasound (US) and x-ray radiographs. Imaging is used in all stages
of brachytherapy and especially in treatment planning and verification.
Although the growing use of imaging has improved the quality of the treat-
ment the patients receive, there are still challenges to overcome. In co-operation
11
with the brachytherapy group of the Royal Surrey County Hospital and after
attending several cervical and prostate brachytherapy procedures two major
issues were identified as predominant.
The first is the lack of the visualisation of the applicator during the intrav-
aginal insertion process in cervical brachytherapy. In cervical brachytherapy
the radiation dose is delivered using an applicator. The applicator is a hollow
apparatus that is inserted through the vaginal canal to reach the cervix area,
this procedure is performed in an operating theatre where the applicator is
guided into position under the guidance of an ultrasound scanner. Ultrasound
is used since it is portable and can provide information about the soft tissue
in real time (as the applicator is being inserted). Although ultrasound is used
to provide information about the position of the applicator in most cases the
applicator is not visible on the ultrasound images. The clinician approximates
the position of the applicator by movements that occurred in the surround-
ing tissue such as the bladder and rectum. Therefore, the placement of the
applicator mostly depends on the experience of the clinician. The applicator
position is the critical for the delivery of the treatment. The applicator position
is used to determine the source location for treatment planning and therefore
misplacement of the applicator could result in inaccurate treatment, increased
levels of toxicity in healthy tissues and even punctures in the uterus during
the insertion process.
The second issue is related to prostate brachytherapy and is the presence
of metal seed artefacts in post brachytherapy CT scans of the prostate. Dur-
ing prostate brachytherapy radioactive sources (seeds) are placed inside the
prostate using a grid called perineum and insertion needles. The insertion
needles are clearly visible on the ultrasound scanner therefore the placement
of the seeds is a routine operation. The operation is then followed by a CT scan
that is used for treatment verification. The verification of the treatment is done
12
by finding the dose delivered to the prostate using the positions of the seeds
and comparing the result to the original treatment planning. Unfortunately,
the seeds placed in the prostate produce multiple artefacts in the CT scans.
This phenomenon makes the verification process difficult and sometimes im-
possible since the prostate is hard to identify and consequently the positions
of the seeds relative to the prostate are not clear. To address these two chal-
lenges, this thesis aims to develop and investigate solutions to the following set
of imaging challenges in brachytherapy:
1. Real time tracking of the applicator position during insertion in cervical
brachytherapy.
2. Artefact filtering for CT imaging of implanted radioactive seeds in the
prostate.
1.2 An Overview of Cancer and Cancer Treatment
1.2.1 What is Cancer?
Cancer is a disease with over 200 types that occurs when normal cells turn into
cancerous tumour cells which divide uncontrollably in many cases invading
other organs and spreading to other parts of the body (metastasising) [1, 2, 3].
Cancer kills by ”living parasitically” in patients consuming essential nutrients
used by the healthy organs or obstruct the regular body functions, causing
complications that can lead to death, for example it can grow into brain blood
vessels causing a stroke[4]. According to the World Health Organisation [1]
cancer is the second leading death cause globally responsible for nearly 1 in
6 deaths.Cancer Research UK reports that 28% of the deaths causes in the
UK can be attributed to cancer [5]. In addition, there are more than 360,000
cases of cancer each year and incidence rates have increased by 7% over the last
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decade [5].The reason it is so hard to treat cancer is due to the fact that cancer
has many different types and can occurred from any type of cell in the human
body. Even if the type of cancer is the same, each cancer is different from
others since the mutations that occurred in the cell are likely to be different
therefore a treatment that is effective for a certain patient will not automatically
be effective for someone else. Figure 1.1 shows the death rate caused by cancer
on a global scale as presented in nature journal [6].
Figure 1.1: Shows the age standardised death rate per 100,000 people globally.
Taken from [6]
1.2.2 Cancer Diagnosis,Staging and Treatment
A patient can be diagnosed with cancer either by having symptoms and self-
presentation at a clinic for diagnosis or through cancer screening. Screening
is the process of carrying out a set of tests or medical imaging to detect cancer
often before symptoms appear. Currently the National Health Service (NHS) of-
fers screening for cervical, breast and bowel cancer as a way of battling cancer
at early stages [7]. The benefits of screening can improve the likely outcome
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due to early diagnosis of the disease. When someone is diagnosed with cancer
the next step (before providing them with the prognosis and treatment options)
is called staging. Staging is the process of classifying the cancer and charac-
terises it throughout treatment. The method that is universally agreed upon is
the TNM scheme that was proposed by the American Joint Committee of Can-
cer (AJCC) and which is fundamentally based on the hypothesis that cancers
that occurred in the same anatomical location and histology share common
patters of growth and similar outcomes [8]. The TNM method is based on the
three following tumour characteristics:
1. T, which refers to the primary tumour size and extent.
2. N, which denotes if the cancer has spread to the regional lymph nodes,
which filter and trap bacteria and are a part of the immune system. If
the primary tumour extends into the lymph nodes is classified as lymph
node spread or locoregional spread.
3. M, which denotes if the cancer has metastasised to other parts of the
body.
For each of the TNM characteristics a numeric subset exists to indicate each
characteristic extent. Those are described below:
1. For Primary Tumour (T) : TX - Tumour cannot be assessed. T0 - no evi-
dence of primary tumour. Tis - carcinoma in situ meaning that the tu-
mour is small and cannot form a tumour but it can develop into cancer
at a future time. T(1-4) - describes the increasing size and extent of the
local tumour in ascending order.
2. For Regional Lymph Nodes (N) NX - Regional lymph nodes cannot be as-
sessed. N0 - no evidence for regional node metastasis. N(1-3) Increased
involvement of regional lymph nodes.
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3. Distance Metastasis (M) MX - distant metastasis cannot be assessed. M0
- no evidence of distant metastasis. M1 - distant metastasis occurred.
The staging data can be provided by different stages and different means.
TNM classifications provides four different classification for each site. These
are the clinical classification (cTNM) which uses clinical assessments before the
patient is first treated and can include various examinations such as physical
examination, medical imaging, endoscopy (a procedure that uses a flexible in-
strument with a camera and a light attached at the end to view the inside of
an organ), biopsy - the laboratory examination of a tissue removed from an
organ - and surgical exploration. cTNM is always essential before selecting a
treatment because it provides all the necessary information to select the most
appropriate treatment. Pathological classification (pTNM) which uses evidence
before treatment and additional evidence obtained from surgery and or patho-
logic examination. This staging provides additional precise data that are used
for the estimation of the prognosis. Retreatment classification (rTNM) is used
for a cancer that recurred after a disease-free interval and finally the Autopsy
classification (aTNM) that occurs upon the death of a patient that did not have
evidence of cancer prior to his passing. Although the TNM system can describe
a cancer accurately the TNM combinations can be categorised into five less dis-
tinct stages and three grades as summarised by the NHS [9]. These are the
following:
• Stage 0 - the cancer is in situ and there is no evidence of metastasis to
the localised lymph nodes or to other parts of the body.
• Stage 1 - the cancer is small and there is no evidence of metastasis.
• Stage 2 - the cancer has grown but has not metastasised.
• Stage 3 - the cancer is larger and may have spread to the localised lymph
nodes and tissue.
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• Stage 4 - the cancer has metastasised to at least one other organ inside
the body.
The grading of the cancer depends on the examination and the nature of the
cancer cells that determine the growth rate of the cancer. Those are:
• Grade 1 - the cancer cells resemble normal cells and do not grow rapidly.
• Grade 2 - the cancer cells do not look normal and are growing faster than
the normal cells of the same type.
• Grade 3 - the cancer cells look abnormal and may grow or spread faster
and more aggressively.
After the cancer staging step the patient is offered the best available treat-
ment or a combination of treatments for his/her disease based on their prog-
nosis. The most popular treatment methods are surgery, radiotherapy and
chemotherapy. Surgery is usually an effective method in early stage cancer if
the tumour is localised. During the operation the surgeon removes the tumour
plus a margin of healthy surrounding tissue and often the nearby local lymph
nodes as a precaution. The side effects of the surgery can vary depending on
the organ or tissue that was removed also there is a risk of the cancer to return
if any cancerous cells were left. Chemotherapy is usually used in combination
with surgery to make sure that all cancer cells remaining will be destroyed.
Chemotherapy methods involve the administration of drugs that stop cancer
cells reproduction and are often used successfully for very specific types of
cancers. There are several side effects for patients treated with chemotherapy
such as breathing difficulties, chest pain, high body temperature etc. Radio-
therapy is a method that uses high energy ionizing beams to target the tumour
and kill the cancerous cells by destroying the DNA strands in the nucleus of the
cells[10]. Radiotherapy’s popularity is attributed to the fact that is an effective
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non invasive method which can be used to kill cancerous cells.Radiotherapy
has also several side effects such as skin irritation, tiredness and hair loss.
1.2.3 Cervical and Prostate Cancer
Cervical cancer occurs in the cervix region of women.Cervical cancer is the sec-
ond most common malignancy to affect women, with over half a million cases
occurring worldwide each year [11].According to Cancer Research UK cervi-
cal cancer is the third most common gynaecological cancer in the UK with a
number of 3,100 new cases per year and 900 deaths per year. Due to improve-
ments in treatment, and diagnosis the death rate from cervical cancer in the
UK has decreased by 70% since 1970.The most important factor in the devel-
opment of cervical cancer is the human papillomavirus infection (HPV). HPV
DNA was found in more than 99% of cervical cancers [12, 13, 14]. For cervical
screening there are three available options [14]. Those are cervical cytology
(most commonly known as Papanicolaou (”Pap”, test), Pap/HPV co-test and
HPV-only test. These tests are perform on cells from the cervix. The staging
of cervical cancer involves biopsy testing, laboratory testing and medical imag-
ing. The treatment for cervical cancer can vary greatly but the most common
treatments for cervical cancer are surgery and radiotherapy.
Prostate cancer is a cancer that only occurs in men and affects the prostate
gland which is a male reproductive organ. The screening for prostate cancer
involves testing of the prostate specific antigen (PSA) level which is a protein
that is released into the bloodstream by the prostate gland and is higher in
the presence of cancer, a second part of screening is digital rectal examination
which involves transrectal testing of the prostate by a physician[12]. The stag-
ing of prostate cancer is carried out using a trans-rectal ultrasound scan with
a biopsy [15]. The most common treatments for prostate cancer involve prosta-
tectomy which is the removal of the prostate, radiation therapy in the form of
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external beam, or brachytherapy which involves the placement of radioactive
seeds in the prostate gland to deliver high radiation dose. These methods are
usually combined with chemotherapy to maximise their effectiveness.
1.3 Medical Imaging
Medical imaging is a set of methods for producing a visual representation of
the inner human body without the need for invasive intervention. The start
of medical imaging began with the discovery of the x-ray by Wilhelm Conrad
Roentgen in 1895 whilst he was experimenting with electricity [16]. Although
the rays were not understood the medical use of this discovery was immediately
recognized resulting to the use of x-rays in the early 19th century to image
broken bones in order to treat them more effective. During the 19th century the
field saw a rapid expansion with the discovery of many different modalities that
use the same principal of projecting radiation through the human body and
observing the outcome using detectors that interpret the data to form images.
Currently there are many different modalities but the most commonly used
are computed tomography (CT), magnetic resonance imaging (MRI), positron
emission tomography (PET) and ultrasound (US).
The role of medical imaging is essential in cancer treatment and it is used
in screening and all the stages of the treatment process, such as in treat-
ment planning, treatment verification and monitoring of the patients to ensure
that the treatment has had the desired outcome. Imaging techniques can un-
restrictedly be classified in two categories those are anatomical imaging and
functional imaging [17]. Anatomical imaging provides - as the name suggests
- structural information of the human anatomy for example and it can detect
a tumour or alteration of the anatomy but it cannot provide any information
about the type of tissues for example if the tumour is malignant or benign.
19
Functional imaging provides functional information about the type of tissue
but is not necessarily anatomically accurate.
1.3.1 Computed Tomography (CT)
CT became available for clinical use in the early 1970s and it was the first
medical imaging modality that was made possible using the computer[16, 17].
CT images are constructed by projecting x-rays though the body at different
angles by rotating the x-ray source on a gantry. Detectors are placed opposite
the source to collect the projection data. CT is mainly an anatomical image
modality and provides little or no functional data.An Image of a CT scanner
along with a CT produced image is shown in the figure 1.2.
Figure 1.2: Shows a conventional CT scanner with a CT image of the abdominal
region.The CT scanner image was taken from [18]
CT scanners output anatomical 2D and 3D images displayed in Hounsfield
units (HU). Hounsfield units are acquired by the transformation of the original
linear attenuation coefficient µ based on the attenuation coefficient of tissue
based on the µ of water as shown in equation 1.1.
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HU = 1000× µtissue − µwater
µwater
(1.1)
The CT scanners collect x-ray transmission profiles through the patient at
multiple angles. The data collected are related to the attenuation of the beam
energy in tissue and by using a filtered back projection (FBP) algorithm a cross
sectional image is constructed [19]. In FBP the scanned data are converted to
sinogram data which are acquired from the transformation from object space
into synograms/Radon space . Sinograms represent each profile projection at
a certain angle by a single line of data in the real space domain . Then the
sinogram is filtered and the inverse Radon transform is performed in order to
obtain the reconstructed image. An image of a sinogram is shown in the figure
1.3 below.
Figure 1.3: Shows the sinogram of the Sheep Logan Phantom as it was pro-
duced in Matlab using the radon function spanning at 180 degrees.[20]
CT has several uses in the medical imaging field. It can be used for diagnos-
ing a diseases, trauma or abnormalities, to plan and guide various interven-
tional or therapeutic procedures and to monitor the effectiveness of a therapy,
for example, cancer treatment. The drawback of CT scan is that it exposes the
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patient to ionizing radiation that could potentially damage healthy tissues in
addition imaging patient with metal prosthesis is difficult because metal im-
plants causes beam hardening and streak artefacts significantly reducing the
image quality.
1.3.2 Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging was established on the basis of a physical phe-
nomenon called nuclear magnetic resonance in which magnetic fields and radio
waves cause atoms to transmit tiny radio signals which are subsequently de-
tected by the scanner in order to form an image [16, 17]. An Image of an MRI
scanner is show in the figure 1.4 below.
Figure 1.4: Shows an MRI scanner [21] with a typical MRI image of the knee
[22].MRI en-composites several different image capture modes.
In MRI systems magnetic fields are produced by large electrical currents
flowing through wires that are cooled down at super conducting temperatures.
There are protons in our body that are positively charged and spin about their
axes like magnets randomly oriented so that their magnetic fields cancel out.
When these protons are placed under a strong magnetic field a portion of them
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will align to the direction of the magnetic field and some in the one opposite
to the magnetic field. Most of the magnetic fields of the protons will cancel
out but a slight excess of the protons will be aligned to the main magnetic
field producing a net magnetisation which becomes the source to produce MR
images.
MRI has solidified its place in modern radiotherapy planning complementing
the use of CT and can be used both as an anatomical and functional imaging
modality. There are several advantages that MRI provides over CT. MRI does
not deliver any ionizing radiation to the patient and therefore is considered a
safer option although it takes longer to acquire imaging data. MR provides
better soft-tissue visualisation and consequently better delineation and is fun-
damentally a 3D modality. There is also evidence provided by that MRI tech-
niques using contrast enhanced, perfusion and diffusion methods can be used
successfully for monitor and asses cancer therapeutic efficiency.
1.3.3 Positron Emission Tomography (PET)
PET is a nuclear medicine imaging method that produces 3D images of the
metabolic function of the body. PET is mainly a functional imaging modal-
ity and does not provide any anatomical information[16, 17]. A PET scanner
detects pairs of gamma rays that are emitted as the result of annihilation of
positrons emitted by a positron-emitting radionuclide (tracer) which is admin-
istered to the patient through intervenes injection. An image produce by a PET
scanner is shown in the figure 1.5 below. Nowadays PET system are usually
incorporated in CT scanners.
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Figure 1.5: Shows a PET image of the brain where the yellow-red regions signify
higher activity[23]
The tracer consists of molecules that are bound with a radioactive isotope.
The molecules can interact with specific proteins or sugars in the body de-
pending on the radio-tracer, therefore making the imaging function specific.
For example, for observing cancer a common tracer that can be used is the
glucose analogue fluorodeoxy-D-glucose (FDG), since tissues absorb sugar to
function the tumour will absorb large quantities of this sugar, resulting in a
strong signal in the PET scanner.
PET is heavily used in clinical oncology. It can be used for the diagnosis of
cancer or to monitor the progress of a treatment. Studies show that when PET
is combined with an anatomical imaging modality such as CT it can have great
impact in both diagnostic and therapeutic aspects of patient management.
Although PET can be a great tool that can provide details about body func-
tion there are some limitations. The patient is exposed to ionizing radiation
that similarly to CT can damage healthy tissues. In addition, the high cost of
producing short-lived radionuclides for PET and specialised chemical synthe-
sis needed on site limit availability.
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1.3.4 Ultrasound (US)
Ultrasound can be used to image internal organs. The ultrasound works on a
pulse - echo principle, an ultrasonic wave travels through the body interact-
ing with the tissue and producing echoes that are subsequently received by
the transducer to form images, since each type of tissue has different acoustic
properties and characteristics and hence interact differently with the ultra-
sonic wave[16, 17]. The ultrasonic wave is produced and detected by a piezo-
electric transducer. An image of an ultrasound system is shown below in figure
along with an ultrasound image.
Figure 1.6: Shows a portable Ultrasound System [24] and an ultrasound image
slice of an abdominal phantom as captured by the author
Ultrasound is usually used to assist in radiotherapy treatment planning es-
pecially if CT data are not available. New emerging technologies, including 3D
ultrasound scanning, are becoming available. Transrectal ultrasound (TRUS)
revolutionised prostate brachytherapy and is a part of the standard procedure
for visualising in real time the placement of the radioactive seeds and for treat-
ment planning .
There are several advantages that ultrasound possesses over CT, including
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reduced cost, live imaging, no ionising radiation exposure to the patient and
high availability/portability. Ultrasound suffers from poor imaging quality in
comparison to CT In cervical brachytherapy ultrasound is used to guide the ap-
plicator to the cervical region but the image quality suffers due to the presence
of air and the applicator may not be readily visible.
A new ultrasound imaging technique is elastography which aims to measure
the stiffness of the tissues by measuring its Young’s modulus. The Young’s
modulus is a mechanical property of linear elastic materials which is defined
as stress over strain. There are two methods of measuring tissue stiffness.
These are strain elastrography which measures the tissue displacements when
a small pressure is applied and shear wave elastography where the speed of
shear waves passing through tissue is measured [25]. According to Gennisson
et al. 2013 [26] the integration of elastography into conventional ultrasound
systems will lead to its routine application in clinical practise and the fusion
of elastography with other imaging techniques will improve diagnostic perfor-
mance.
Another ultrasound imaging technique is Doppler ultrasound. The Doppler
effect is a change in frequency of a wave caused by the relative motion of the
observer to the source. The change in frequency depends on the relative speed
between the observer and the source. In ultrasound the Doppler effect occurs
when a sound is deflected from moving scatterers such as red blood cells[27].
Doppler ultrasound is a technique for measuring blood flow and therefore could
potentially be used for identifying the location of the tumour or for image reg-
istration.
The ultrasound speckle pattern is an image artefact produced by the over-
lapping of returning echoes to the transducer from the tissue structure. As
it is a result of the tissue structure it is deterministic. A variety of authors
[28, 29]have analysed data from ultrasound scans and highlighted that speckle
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patterns can contribute in tissue characterisation and enable image tissue
tracking.
Applicator tracking capabilities during insertion in cervical brachytherapy
(by having a robust system, that can guide the applicator to the right location)
could possibly change the standard of care for this treatment. Currently there
are no available system that can provide such capabilities. New ultrasound
imaging technologies such as elastography and Doppler ultrasound could be
used to improve the tumour localisation by providing extra soft tissue informa-
tion. Non-rigid body registration of ultrasound images with CT or MRI will be
beneficial if a robust method of calculating deformations in ultrasound images
is developed [30, 31, 32].
1.3.5 Image Registration in Medical imaging
Image registration is the process of overlaying images of the same scene at dif-
ferent times, different viewpoints and/or different imaging modalities or sen-
sors [33, 34, 35]. Most of the image registration methods follow the four steps
detailed below:
1. The first step is feature detection where distinctive features of the images
such as contours, edges, points etc. are manually or automatically de-
tected. Those points are called control points.
2. The second step is called feature matching. In this step, correspondences
between the detected features in the images are established.
3. The third step is the transform model estimation. In this step the mapping
functions are estimated. Mapping functions are mathematical formulas
deduced to achieve the matching of features in step two.
4. The final step of image registration is re-sampling and transformation. In
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this step the images are transformed based on the mapping functions and
interpolated in case of non-integer pixel values.
In medical imaging, registration is usually used to combine images from differ-
ent modalities in order to enhance the quality of diagnosis and treatment [34],
for example the registration of MRI with positron emission tomography (PET).
There are two classes of image registration in medical imaging called rigid body
registration and non-rigid registration. The difference between the two meth-
ods is that rigid body registration does not compensate for tissue deformation.
Although the rigid body registration simplifies the registration process, many
organs deform on a regular basis such as the breathing lungs, beating heart
etc. In addition, imaging equipment has limitations so the registered images
are not corrected for geometrical distortions, such as due to variations in the
field strength in MRI. Nonrigid registration aims to tackle this issue but this is
very challenging, especially if the tissues are deformed significantly. Currently
the most common methods to register CT or MRI with ultrasound are rigid
body registration methods. Nonrigid body image registration between MR/CT
and ultrasound could be beneficial during cervical brachytherapy since it will
improve the process of guiding the applicator in position more accurate by
providing more realistic information about the deforming, surrounding tissue.
There are methods that achieve that by an image to a model registration [36].
1.4 Brachytherapy
Brachytherapy is a method of radiotherapy treatment that involves the place-
ment of sealed radioactive sources near or inside the cancerous area in order
to deliver a therapeutic dose. In principal a high dose can be delivered locally
to the tumour sparing healthy tissue [37, 38].
28
1.4.1 Cervical Brachytherapy
Cervical brachytherapy has improved considerably during the past decades
by incorporating medical imaging and moving to three-dimensional planning
allowed better coverage of the tumour while sparing healthy tissues. According
to the International Federation of Gynecology and Obstetrics (FIGO) cancer
stages IB2 to IVA should definitively include brachytherapy as a part of their
treatment management [39]. Usually cervical brachytherapy is combined with
external beam radiotherapy and chemotherapy for improved results. There are
two methods to perform cervical brachytherapy those are the intracavitary and
interstitial methods. Intracavitary brachytherapy is the most common method
and involves the placement of an appropriately selected applicator near the
cervix area. An applicator is a hollow apparatus in which a radioactive source
may be loaded and that is used to deliver the dose to the tumour two of the
most common applicators are the tandem and ovoid and the tandem and ring.
Figure 1.7 shows an image of a ring tube applicator that was used in Royal
Surrey County Hospital.
Figure 1.7: Shows an assembled ring applicator used in cervical brachytherapy
[40]
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Interstitial brachytherapy uses a transperineal template though which hol-
low tubes are inserted straight to the tissues for dose delivery.
Although both methods appear to have similar results intracavitary brachyther-
apy is the most commonly used procedure and its performed in four stages.
These are:
1. Treatment planning: a biopsy is performed of the tumour in order to iden-
tify the extent of the cancer. This process is called staging (as described
above). Then using imaging modalities such as MRI and CT the cancer
is imaged and a plan for the radiation dose distribution is created. In
addition to this a prescription is selected. The prescription can be LDR
(low dose rate), HDR (High Dose Rate) or PDR (Pulsed dose rate). High
dose rate is preferred since it provides faster treatment compared to LDR
and better protection from radiation exposure to the clinical staff while
the toxicity levels remain the same. Pulsed dose rate aims to mimic the
radiobiological effects of LDR but it requires hospitalisation therefore it is
not widely used.
2. Applicator Placement. During this step an applicator is placed into the
patient through the vaginal canal to reach the cervix region (tumor) usu-
ally with the use of ultrasound imaging for guidance.
3. Post insertion scanning/treatment plan optimisation. After the placement
of the applicator the patient usually undergoes a CT or an MRI scan in
order to verify the position of the applicator. Then the dose plan is slightly
modified if there are small differences from the planned applicator posi-
tion. If the insertion is suboptimal the second and third steps are re-
peated.
4. Treatment delivery. During this step the clinicians attach the applicator
into the after loading system and leave the operation room. The dose is
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delivered according to the dosimetry (3) plan using the after-loading sys-
tem. An image of the after loading system is shown below in figure 1.8.
The after-loading system positions a set of sealed sourced at a range of
positions inside the applicator for a range of dwell times under computer
control to achieve the prescribed treatment plan. Imaging in brachyther-
apy treatment is extremely important since it provides critical information
that result in the correct treatment plan.
Figure 1.8: Shows the Flexitron after-loading system that is used for cervical
brachytherapy. The hollow tubes of the applicator are connected to the system
in order to deliver the dose automatically [41]
Research about combining both methods using one single applicator with
some encouraging results with appropriate dose coverage was done by Di-
mopoulos et al. 2006 [42] using the Vienna applicator [43]. That lead to further
research in hybrid brachytherapy and the development of hybrid applicators
[44].
Advancements in medical imaging such as MRI and CT have improved the
treatment planning significantly allowing planning to move away from two di-
mensional (2D) to three dimensional (3D). Consequently, this improves the de-
lineation and coverage of the tumours, as well as improved avoidance of sur-
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rounding organs. Therefore, very high rates of local control with a reduction
in morbidity can be achieved by using these modalities in brachytherapy treat-
ment [37, 45, 46].
Currently groups such as GEC-ESTRO (Groupe Europe en de Curiethera-
pie and European Society for Radiotherapy and Oncology) and ABS (American
Brachytherapy Society) provide recommendations for transitioning to MRI/CT
based brachytherapy due to the advantages in planning and dosimetry [47, 48,
49]. The MRI image guided adaptive brachytherapy approach is considered to
be the new state of the art treatment for cervical cancer because it allows vi-
sualisation of the tumour in relation to the applicator and the organs at risk
(OAR) at the time of brachytherapy, enabling dose adaptation to the target while
sparing normal tissues at the same time [50]. In the UK, image-guided adap-
tive treatment is gaining momentum with an increase of usage from 21% of
centres in 2008 to 71% in 2011 [51].Although many improvements have been
made due to these advancements and many well-resourced centres recommend
the use of MRI for post insertion imaging, still today the most common imaging
modality to assess intracavitary implants is planar X-ray imaging [52, 53]. It
was proved that the soft tissue imaging capabilities provided by MRI improve
the accuracy of implantation which has resulted in greater local control and
decreased toxicity levels. One imaging modality that is widely available and
has soft tissue imaging capabilities is ultrasound. In addition, ultrasound is
economical and portable which means that it can be used in the operating
room.
Applicator positioning is critical for performing brachytherapy since the
dosimetry treatment plan is based on the position of the applicator in the pa-
tient’s anatomy [54, 55]. Often the insertion of the applicator is done ”blindly”
by the clinicians increasing the risk of perforation and the possibility of punc-
turing the uterus. There are several reports from various researches that mea-
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sure the movement of the applicator between fraction and reporting the effect
of applicator position in regards to the delivered dosed [56, 57, 58, 59, 60, 61,
62, 63] all the studies report positional differences of more than 1 cm.
Grisby et al. 1993[56] measure the geometric movement between the first
and second intracavitary implant of the applicator in relation with the pelvis
for forty patients, they reported that the average magnitude of displacement
was between 1 to 1.5 cm that affect the delivered dose by 35% in some regions.
Kim et al. 1995 [57] reported variations of more than 1 cm using orthogo-
nal radiographs to measure the variation in applicator position between each
brachytherapy session for 17 patients. Huerta et al. 1998 [59] measured the
applicators geometric variation for 18 consecutive patients using isocentric or-
thogonal film where the pelvic bone structure was used for reference the study
reports translational variation of the applicator position for all patients of 6.5,
5.9, and 7.7 mm respectively, in the patient’s superior-to-inferior (SI), right-
to-left lateral (RL), and anteriorto-posterior (AP) direction and the rotational
variation was 3.4, 4.6, and 6.0 degrees in the patient’s coronal, transverse,
and sagital planes.The difference in applicator positions have a direct affect on
the dose received by the cancer and the nearby organs.
Ultrasound is mainly used during the insertion process to guide the ap-
plicator to in an ideal position. A ”good” image of the applicator during the
insertion process is shown in figure 1.9. One of the methods used to guide the
applicator in position is intraoperative ultrasound. According to Watkins et al.
2011 [64] the risk of perforation is between 2% - 14%, but if intraoperative
ultrasound is performed to guide the insertion perforation risk is minimised
to less than 1%, Schaner et al. 2013 [65] also reports that the risk of perfo-
ration is reduced to 2%. Intraoperative ultrasound performed by monitoring
the applicator position during cervical brachytherapy with the use of a trans-
abdominal probe. This is the standard insertion monitoring technique used
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currently in the UK.
Figure 1.9: Show an image of the applicator guided to position during an in-
sertion captured with a transabdominal ultrasound probe. The white arrow
tips show the tip of the applicator and the black arrow tip shows the uterus.
The image was taken from [65]
Although transabdominal ultrasound imaging provides guidance of the ap-
plicator, the applicator itself is not clearly visible in all cases due to the materi-
als used in the applicator or tissue dilations during insertion. Another system
for applicator tracking was proposed by Xia et al. 2014 [66] using an infrared
camera and reflective markers that are attached to the applicator. The ap-
plicator position was measured relative to the markers attached, the system
was then tested in a phantom study with known displacements of 15mm. The
system achieved 4 frames per second and a standard deviation in position mea-
surement of 0.44 mm. Electromagnetic tracking systems are widely used in the
medical environment for tracking biopsy needles, and equipment such as ul-
trasound probes for 3D acquisition but so far there are no known uses in the
tracking of gynaecological applicators.
A recent investigation proved that electromagnetic tracking systems (EMT)
can be used for quality assurance in implanted catheters in brachytherapy with
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improved residual mean errors of less than a millimetre by Damato et al. 2014
[67] another study by Bert et al. 2016 [68] shows the potential of the EMT in
interstitial brachytherapy. Mehrtash et al. 2014 [69] used an EMT to evalu-
ate the accuracy of image guided catheter placement for cervical brachyther-
apy using a phantom after two experiments the mean error of placement was
2.98 mm when compared to the CT data.Zhou et al.2013[70] also use an EMT
tracker to track the catheter positions during prostate brachytherapy measur-
ing errors of 1.6 ± 0.2 mm under optimal conditions. That shows the potential
of using electromagnetic tracking systems for applicator tracking in cervical
brachytherapy.
1.4.2 Prostate Brachytherapy
Prostate brachytherapy was one of the earliest application of radiation for treat-
ment, as early as 1914 by Pasteau and Degais. During the past decades the
popularity of prostate brachytherapy due to improvements in medical imag-
ing (transrectal ultrasound-TRUS), reproducible technique for seed placement.
The most common technique for prostate brachytherapy in the UK is the in-
traoperative planning (three-stage) technique [71, 72]. This method has three
steps which are explained below:
1. Treatment planning: during the treatment planning the patient has a
TRUS examination with a catheter in order to obtain a three-dimensional
model of the prostate for treatment planning. Using the aforementioned
data the number of seeds needed for treatment is determined by evaluat-
ing the size and the extend of the cancer in the prostate region.
2. Operation: During prostate brachytherapy a transperineal grid guide is
used to guide the needles and a transrectal ultrasound is performed. Dur-
ing the operation the seed placement is guided by monitoring the position
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of the needles on the ultrasound system to ensure the correct placement
of the seeds while the clinician communicates each seed placement with
the clinical physicists to ensure the treatment plan is followed.
3. Treatment verification: is done by performing post implant dosimetry, by
using CT scans of the prostate the scans are then used to form a three-
dimensional dose volume histogram that quantifies the delivered dose.
Post implant dosimetry is important to verify the delivered dose since the
pre-treatment plan does not always agree with the post treatment veri-
fication. It also helps in anticipating infections for example caused by
misplacement of the seeds near the bladder.
There are another two commonly used brachytherapy procedures that mainly
differ in the planning process of the treatment. These planning methods are
interactive planning which refines treatment plan by using the position of the
needles as feedback thus dynamically change the seed placement and the dy-
namic dose calculation and which involves constant updating of the dose cal-
culation taking into consideration the seed positions.American Brachytherapy
Society doesn’t suggest any preferred method for performing the procedure but
they recommend post prostate treatment verification for all patients [73].
Although the improvements in medical imaging have revolutionised the prostate
brachytherapy procedure allowing for pre-treatment planning, seed placement
guidance during brachytherapy and the means to perform post implant dosime-
try and evaluation of the treatment, there are still challenges to overcome es-
pecially in the post implant dosimetry due to the difficulty in contouring the
prostate [74].
The most common technique for post implant dosimetry is performed by tak-
ing a CT scan of the prostate region [75, 76]. In each of the slices the prostate is
contoured (outlined), the urethral location is estimated for most of the cases by
a comparison with the ultrasound images or by the use of the catheter. The or-
36
gans near the prostate such as rectum and bladder are also contoured and the
number of the implanted seeds are then counted and crossed checked. The
dose is subsequently countered for each organ including the prostate. Even
though the process sounds very simple there are three well documented un-
certainties with this method, these are i) the seed displacement which refers
to the deviation of the placed seeds in regard to the originally planned posi-
tion, ii) the prostate volume may change from the planning study and finally
iii) prostate movement during implantation although stabilisation needles are
used. In addition, the contouring of the prostate and the surrounding organs
which is essential for helpful post implant dosimetry is heavily reliant on the
diagnostic radiologist who is required to contour each region. According to De
Brabandere et al. 2012 [77] there is a great inter-observer variability in defini-
tion of the prostate volume between post MRI and CT images of 7%. MRI was
also proven the superior modality to use for organ contouring but it performs
poorly on locating the seeds [78]. Artefacts make the verification process of the
treatment planning harder and sometimes impossible. A CT image containing
artefacts from the implanted seeds is shown in figure 1.10.If the artefact could
be removed then the relationship between the seeds and the soft-tissue of the
prostate and surrounding tissues could be used to improve the radiographers
contouring hence improving the contouring of the prostate and the results of
the post implant dosimetry.
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Figure 1.10: Multiple metal artefacts present on a prostate CT image. The
white cross-like structures are the implanted radioactive seeds placed around
the prostate. The seeds are point-like and the cross-like structure is a CT
reconstruction artefact. Beam hardening and streak artefact are caused by
the presence of the seeds in the images making the accurate contouring of the
prostate impossible. Therefore, resulting in inadequate treatment verification.
The image was provided by collaborators at the Royal Surrey County Hospital
In previous work, several researchers have developed filters for metal seed
artefacts reduction [79, 80]. These filters can be grouped into four categories:
sinogram correction, iterative image reconstruction, adaptive filtering methods
and modelling based filters. The first two categories of filters require access to
the raw CT data which may be difficult and impractical to implement in the
clinical environment due to the need for direct access to the CT scanner’s raw
data. The third and fourth category can suppress the artefact but are heavily
reliant on estimating the nature of the artefact. Although these filters can be
flexible and be used in a variety of cases they are not very effective when it
comes to filtering multiple artefacts in the same image (e.g. more than 10).
For example, in the post prostate brachytherapy CT scans there may be many
artefacts in a single CT slice which produces overlapping streak artefacts and
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in these cases some types of filter may not be as effective as others. A method
for filtering metal artefacts from images was proposed by (Bal & Spies 2006)
[79]. The method consists of three major steps which are:
1. Adaptive filtering: which reduces the noise content and smooths the streaks.
2. Clustering: the image is segmented into different regions depending on
the different materials for example, air, soft tissue, bone and metal. Then
the average of each region is assigned a value in Hounsfield Units. The
Hounsfield scale transforms the x-ray attenuation coefficients in relation
to the attenuation coefficient of water. Then the segments are forward
projected into sinogram space. Sinograms are used to visualise the Radon
transform (Forward Projection) results which show the image intensity
integral along a radial line at a specific angle.
3. Completion: in the completion step the metal segments are replaced by
other materials around them using interpolation and then the sinogram
is backward projected (inverse radon transforms) to produce the filtered
image without the artefacts from the metal.
Results presented from this methodology significantly improve the quality of
the images. Li et al. 2011 [80] improved the previous method by including
a steering filter in the first step which smooths the artefacts and the recon-
structed image is reconstructed from a combination of the corrected image
and the image component free of artefacts.
Although these methods exist they are for general use for any type of metal
artefact such as artificial limbs and thus are not optimised for the problem of
artefacts due to implanted radioactive seeds. In prostate brachytherapy there
is a large number of small metal implants which produce artefacts on the CT
images (figure 1.10) and therefore the problem is uniquely challenging. Accord-
ing to a review of three commercially available metal artefact reduction methods
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none of them were particularly beneficial for dental artefacts which are similar
in nature with metal seeds artefacts [81]. In addition researches stress the
need for automatic segmentation methods for prostate to avoid intraobserver
variability [82].
New emerging techniques such as image inpainting have found success
in restoring parts of images with relative success. Image inpainting is com-
pleting missing or corrupted parts of the images by using information from
the image and complex algorithms to replace the missing data. There is a
plethora of algorithms that were developed for restoring images such as in
[83, 84, 85, 86, 87, 88, 89] but no evidence of their application in filtering
post prostate CT scans was found through my search to date (24/09/2018).
Since the information on those scans is lost using image inpainting theoreti-
cally the contour of the prostate and the texture of the surrounding tissue will
be preserved.
1.5 Thesis Overview
The main aims the work presented in this thesis were to investigate and develop
i) an electromagnetic tracking system can be used in a clinical setting to track
the position of the applicator during cervical brachytherapy and ii) develop
a method of filtering metal seed artefacts from post prostate brachytherapy
CT images and to evaluate the effects on the contoured prostate in treatment
verification.
In this thesis, the experimental work is presented to investigate if the elec-
tromagnetic tracking system can be used for tracking the cervical brachyther-
apy applicator in-vivo and the development of such a system is presented. This
work proposes a methodology to investigate the accuracy of the tracking system
in regard to the CT scanner that is currently used for treatment planning. The
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proposed methodology was tested on a gynaecological phantom. This led to a
clinical trial that started in January of 2016 and it is still on-going. At time
of writing six patients agreed to take part and eighteen datasets were collected
from these patients. Furthermore, a methodology was developed for filtering
metal seed artefacts from post prostate brachytherapy CT scans that can be
used in the clinical setting. The filtering methodology can be applied directly to
the CT images and utilises an automatic segmentation of the metal seed arte-
facts allowing for fast filtering of a whole dataset without observer intervention
and in a timely manner which is critical for clinical applications. The filtering
methodology is currently in clinical trial.
The work in this thesis has been carried out in collaboration with the Royal
Surrey County Hospital (RSCH).
The first stage of this work was observation of several prostate and cervical
brachytherapy treatments at RSCH to familiarise the author with the proce-
dure and to identify potential improvements that can be made. After discussing
with the clinicians, the author proposed the aforementioned topics. In chapter
2 the work for the development of the tracking software using the applica-
tion program interface (API) provided by Northern Digital Inc. (NDI, Ontario
Canada) is presented along with the experimental work that led to the de-
velopment of the tracking methodology for evaluating the clinical use of the
electromagnetic tracking system.
In chapter 3, a clinical trial for evaluating the accuracy of the tracking sys-
tem methodology in comparison with the CT scanner is presented. During the
clinical evaluation imaging datasets were collected during brachytherapy op-
erations and used to compare the position of the applicator as it was captured
by the tracking system in the operating room and immediately prior to the CT
scan (with measurement of the position of the applicator as it appeared in the
CT scans). The results from analysing the data provide information about the
41
accuracy of the tracking system in comparison to the CT scans and the results
from other studies using similar means.
In chapter 4 the work done towards the development of a methodology for
metal seed artefact filtering from post prostate brachytherapy CT scan is pre-
sented. During the development of the methodology several algorithms were
tested. The final methodology was also used to filter a breast dataset filtered
with an alternative method plus post prostate brachytherapy CT images pro-
vided by our collaborator in RSCH. Results from the final methodology are
presented and discussed.
Following the work presented in chapter 4 a trial to evaluate the effect of
filter in post prostate brachytherapy CT scans of patients is presented in chap-
ter 5. The study aims to measure the inter-observer reliability of contouring
the prostate in unfiltered and filtered in post prostate brachytherapy CT scans.
Two observers from the RSCH agreed on contouring 11 patient dataset for this
study. The study is still on-going but some preliminary results are presented
and discussed.
Finally, in chapter 6 the outcomes of the thesis will be outlined and dis-
cussed. In addition, future work based on the research carried out so far will
be presented.
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Chapter 2
The Development of an
Electromagnetic Tracking System
for Cervical Brachytherapy
2.1 Introduction
Cervical cancer is one of the most common cancers that affect women. In
2014 it was the fourth most common cancer in women and the fourth most
common cause of cancer death in women. One of the most effective ways of
treating cervical cancer up to stage 1-B is brachytherapy. Brachytherapy is a
radiation therapy method that involves the placement of a radioactive source
in near proximity to the cancerous cells. The dose in cervical brachytherapy
is delivered with the use of an applicator that is placed during an operation
through the vaginal canal to reach the cervix area. The dose in then deliver
with the use of an after- loading system.
Although the growing use of imaging in brachytherapy improved the over-
all quality of the treatment as it is used in all stages of the treatment there
are still challenges to overcome. After observing several cervical brachyther-
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apy procedures at Royal Surrey County Hospital, the main issue is the correct
placement of the applicator. Although ultrasound is used to provide informa-
tion about the position of the applicator during the insertion process, in most
cases the applicator is not visible on the ultrasound images. Thus the clin-
icians estimate the position of the applicator by movements that occurred in
the surrounding tissue. Therefore, the placement of the applicator mostly de-
pends on the experience of the clinicians. The applicator position is used for
treatment planning therefore misplacement of the applicator could result in
inaccurate treatment, increased levels of toxicity in healthy tissues and even
punctures in the uterus during the insertion process.
Electromagnetic tracking systems are currently in use in other medical pro-
cedure for guidance of needles or used for image registration. Such a system is
usually provided with ultrasound systems for registration between ultrasound
and MRI images. Electromagnetic tracking systems work in principle using
electromagnetic induction and Lenz’s law. A known electromagnetic field is
generated by the transmitter of the system and the variation in current in the
coils inside the sensors is measured and then formulated in positional data.
At time of writing there is no evidence of a electromagnetic tracking system for
brachytherapy applicator placement and therefore using such a system could
provide real-time tracking of the applicator by overlaying its position in the
ultrasound images.
The benefits of the electromagnetic tracking technologies are that they are
flexible, easy to integrate and can be used with other imaging modalities to
guide equipment accurately and non-invasively. The impact such a system
could have could potentially make cervical brachytherapy more affordable due
to the fewer CT scans required, reduce the time needed for the operation to
place the applicator and improve the quality of the treatment.
In this chapter the author will explore the methodology of developing a sys-
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tem for tracking the applicators used in cervical brachytherapy presenting ex-
periments and the process of developing such a system.
2.2 Methodology
2.2.1 Introduction
The author attended several cervical and prostate brachytherapy operations at
The Royal Surrey County Hospital, to gain first-hand experience of the chal-
lenges to address in this work. During the procedure one of the main focuses
of the clinicians was the correct placement of the applicator. To enable track-
ing of the movements of the applicator the bladder was filled with water to give
a stronger signal to delineation in the ultrasound scanner. The ultrasound
images acquired during the insertion were very unclear regarding the position
of the applicator as shown in the figure 2.1 below. This is needed to avoid
puncturing of the uterus or cause any perforations.
Figure 2.1: The image was taken from [65] and shows the tip of an applicator
shown with the white arrows using ultrasound during cervical brachytherapy
as it can be observed the tip of the applicator is dim and usually not clearly
visible as in this case. The black arrows show the position of the Uterus
45
Currently an electromagnetic tracking system (Ascension 3D TrackStar) is
used to track the ultrasound probe during image registration. The main ques-
tion to achieve applicator tracking was to examine if the electromagnetic track-
ing system could potentially be used to solve this issue. The following section
explains the methodology and experimentation during the research period to
examine this possibility. To develop the new tracking system methodology and
investigate the hypothesis a new software was developed to enable the use of
the system independently. The system is required to track the applicator pro-
viding sufficient accuracy ideally under than the 5 mm which is minimum error
reported in the literature for applicator position displacements, while the sen-
sor its attached to the applicator during the operation. This involves tracking
through human tissue in the presence of metal materials such as tungsten al-
loys which are used in the current brachytherapy applicators. The experimen-
tal planning took into consideration these requirements and an experimental
plan was created to address those questions. The experimental overview can
be seen in the table 2.1 below.
Number Experiment Purpose
1 Software Testing and Initial Pre-
cision measurements
Test the developed software and
obtain the initial precision for
the tracking system, emulating
effects of tissue.
2 Tracking Near Metals Investigate how metals in near
proximity to the sensor affect
the measurement. (some met-
als are used in applicator de-
signs).
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3 Method of placement inside the
applicator
Examine if the method for plac-
ing the sensor inside the appli-
cator is robust and accurate to
meet the real-life conditions of
operation.
4 Prototype Tracking System Cal-
ibration and Evaluation
Evaluate the accuracy of the
tracking system and explore the
deformation field of the sensor.
5 Gynaecological Phantom trial Evaluate the methodology that
will be used for the clinical eval-
uation of the tracking system.
Table 2.1: Provides an overview of the experiments that were carried out lead-
ing to the clinical trial. In each step a key aspect of the tracking system was
focused on until it was evaluated allowing the author to proceed to the next
experiment.
An ideal solution for the issue can be seen in figure 2.2. By providing the
means to accurately track the applicator the brachytherapy procedure could
change drastically providing better dose delivery to the tumour. In addition,
the treatment planning could be done prior to the insertion process and the
time needed for each patient could be decreased.
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Figure 2.2: Shows an ideal solution for optimal tracking of the applicator. The
tracking software and image registration capabilities are integrated into the
ultrasound system for an all in one solution. The Transmitter will be ideally
place on top of the patient hanging from the ceiling of the operating room to
maximise the tracking range of the sensors.
The next section will describe the materials used in the experiments pro-
viding detail about their operation. Lastly the experimental plan of verifying
and developing the tracking system will be presented.
2.2.2 Materials
Magnetic Tracking System
The TrackStar 3D guidance electromagnetic system (Ascension Technology Corp,
Shelburne, VT USA) was used for the experiments in this work. The system
can track up to four sensors with six degrees of freedom accuracy 1.4mm RMS
and 0.5 degrees RMS, and its measurement rate is 80 Hz. The available system
consists of a transmitter and a single Model 800 sensor. A model 55 sensor
was purchased for tracking the tip of the applicator since it can fit through the
bore of the applicator. Figure 2.3 shows the tracking system, the transmitter
with its orientation (x,y,z) and the model 800 sensor. In addition, the table 2.2
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below shows the specification for the sensors when used with a medium range
transmitter.
Figure 2.3: Shows the individual components of the electromagnetic tracking
system and its coordinate system [90].
Sensor Performance Motion Box
(From Transmitters Centre)
Dimensions
Model
55
X = 16 cm to 32 cm
Y = ±10 cm
Z = ±10cm
Length = 300 mm
Outer Diameter (OD) = 0.56 mm
Cable Length = 2m
Model
800
X = 20 cm to 66 cm
Y = ±28 cm
Z = ±30cm
Length = 19.8 mm
Outer Diameter (OD) = 7.9 mm
Cable Length = 3.3m.
Table 2.2: Shows the model 55 and 800 sensor specifications [90].
Applicator Set
The applicator set that was used during the experiments was a Nucletron
CT/MR ring applicator set 45 deg (Elekta AB, Stockholm Sweden). Modern
applicator are made out of materials such as Polyphenylsulfone(PPSU), Epoxy
Poly-vinylester glass fibre, and Tungsten metal alloy. An image of the applicator
is shown in figure 1.7.
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Blue Phantom 2
The blue phantom 2 is a water tank that is primarily used for radiotherapy
beam commissioning. It is equipped with an apparatus that can move a small
platform in the three-dimensional space with an accuracy of 0.1 mm. It was
used in this project to calibrate and evaluate the tracking system in conditions
similar to brachytherapy. An image of the phantom is shown in figure 2.4.
Figure 2.4: The blue phantom that was used during the experiments.
Gynae Phantom
An abdominal gynae phantom that is primarily used for training of the inser-
tion process for cervical brachytherapy. An image of the phantom that was
used during the experiments is shown in figure 2.5 below.
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Figure 2.5: The Gynae phantom that was used during the experiments.
Tracking Software
The tracking software was developed by the author in Visual C++ (Microsoft
2015) using the API that was provided by NDI (Ascension Technology Corp,
Shelburne, VT USA). The software obtains raw data from the tracking system
and visualising them and storing them in text format. In addition, it provides
the capability to read the setup of the device and get timestamp on the samples.
Calibration Phantom
The calibration phantom was design by the author with the purpose to cali-
brate the electromagnetic tracking sensor before use. An image of the phantom
is shown in the figure 2.6 below. By placing the sensor in the measurement po-
sition data position data were collected that were then used for the calibration
of the sensor.
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Figure 2.6: The Sensor calibration phantom that was used during the trial run
experiment to calibrate the sensor before capturing data using the electromag-
netic tracking system. The distance shown in purple is 5cm and the red 20
cm. Those position were used as references for calibration
Data Analysis
The software that was used for the analysis of the experimental data was Mat-
Lab [20]. Matlab is programming language that is commercially available by
MathWorks and it was used extensively for the analysis of the experimental
data.
2.3 Experiments
2.3.1 Experiment 1: Software Testing and Initial Precision
Measurements
The aim of the experiment was to test the developed software. The software
was required to collect the raw sensor values in real time and plot those values
in two orthogonal, two dimensional graphs showing the current position of the
selected sensor. The second aim of the experiment was to obtain a first estimate
of the precision of the sensor while introducing slabs of solid water varying
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in thickness and a human torso between the transmitter and the sensor to
simulated the transmission of signals inside a human body. Solid water is a
material with the same electron density as the human body.The setup of the
experiment is shown below in figure 2.7.
Figure 2.7: The Setup for the first experiment. The red circle shows the position
of the sensor, the blue circle shows the transmitter and the green square the
solid water slabs.
To evaluate the developed software several shapes were drawn in on graph
paper grid. The paper was then securely attached to a bench using duct tape
and the tracking system was used to scan the shapes freehand. At the same
time the software was programmed to update the graphs and the dimensions
of the shapes should be roughly equal to the real dimensions.
The precision of the sensor was measured by securing the sensor at a known
distance (25cm) from the transmitter to ensure that is in the middle of the
tracking window of the electromagnetic tracking system to ensure a good signal
to the sensor. Then several captures of the position of the sensor were made
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using the software program, both with nothing between and with solid water
and a human torso between the transmitter and the sensor, to examine if there
is any variation in precision in the presence of a human body. The solid water
thickness was varied between 0 and 20 cm in incremental steps of 5 cm to
emulate the thickness of the human body. The sensor used for this experiment
was the model 800 sensor because it was the only available sensor at the time
of the experiment. The RMS error was measured for each capture using the
following equation:
RMS =
√√√√ N∑
i=1
(xi − x¯)2
N − 1 (2.1)
where N is the total number of data points, x¯is the mean value of each
measurement and xi the ith measurement, thus, obtaining the precision of
the sensor.
2.3.2 Experiment 2: Tracking Near Metals
The aim of the experiment was to explore how the tracking system will perform
in the presence of different metals such as tungsten alloy which is present
in the current applicator. Although the exact tungsten alloy that is used in
the applicator is not made known by the manufacturer, tungsten carbide was
used as a readily available tungsten containing material. For this experiment
the metals used were aluminium oxide, steel, tungsten carbide and brass. The
experiment setup is shown in figure 2.8.
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Figure 2.8: The Setup for the Second Experiment. The sensor is shown in red
and the Transmitter in green. The distance between the two was 25 cm.
The model 800 sensor was mounted at a fixed location to avoid any move-
ment 25cm away from the transmitter to ensure a good signal out of the sensor.
The position was first sampled without any interference from the metal and was
used as a reference for the following data acquisitions. To measure the effects
of each metal a grid was made around the sensor and the metal was placed in
each position to measure the effect of the metal when placed near the sensor.
In addition, in each capture, metal was placed near and on top of the sensor to
observe how it effects the tracking values. The metals used in the experiment
are shown in the table 2.3 below along with their magnetic susceptibility.Then
the error introduced to the system in each position was measured as the differ-
ence of the initial sensor value and the measured valued when the metal was
in position.
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Material Magnetic Susceptibil-
ity ×10−6cm3mol−1
Dimensions
Width,Length,Height
Aluminium Oxide -37 (diamagnetic) 1.1 cm , 7 cm , 0.2 cm
Brass -8 (diamagnetic) 1.1 cm , 7 cm , 0.2 cm
Tungsten Carbide +10 (paramagnetic) 3cm , 1 cm , 0.4 rhom-
bus
Steel Ferromagnetic 1.1 cm , 7 cm , 0.2 cm
Table 2.3: Shows the dimension and the magnetic susceptibility of metals used
in experiment two
2.3.3 Experiment 3: Placement of tracker inside the appli-
cator
The aim of the experiment was to investigate the precision and the reproducibil-
ity of placing the new sensor inside the applicator. The model 55 sensor was
placed inside the applicator using a plastic sleeve to reduce the sensor move-
ment and provide a tight fit. To achieve this the applicator was placed between
two plastic blocks firmly at a distance of 16 cm away from the transmitter as
shown in the experiment setup in figure 2.9.To that distance the sensor is at
the middle of its motion box and that ensures a strong signal coming from the
sensor.
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Figure 2.9: The setup for the experiment. The blue square indicates the posi-
tion of the transmitter. The red square shows the applicator with the plastic
blocks that were used to hold it in place. The green region shows the track-
ing device which was connected to the pc to measure position data from the
sensor.
Then sensor was inserted in the applicator until it reached its final position
near the end of the applicator. The first measurement was used as a reference
for the comparison between following measurements from five repeated sensor
insertions. In addition, in the final insertions the cable was deliberately shaken
to measure if there was any significant change in the position measured shown
by the tracking system. The data from these captures enable measurement of
the average error and the RMS value which gives an indication of the precision
for the model 55 sensor.
The average error was calculated using the following equation
EAverage =
1
N
N∑
i=1
(Pref − Psample) (2.2)
where Pref is the reference position of the sensor inside the applicator ,
Psample is the position of the sample and N is the number of samples.
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2.3.4 Experiment 4: Prototype Tracking System Calibration
and Evaluation
The aim of the experiment was to calculate the accuracy of the tracking system
using the model 55 sensor in conditions emulating a human body (blue phan-
tom) and to also explore the possibility of calibrating the deformation field of
the sensor to improve the accuracy at distances outside of the sensors motion
box. A deformation field is a set of deformation vectors for all the points in a
3D region of space. The deformation vector specifies the displacement from
the measured position to the true position. The data for the calibration and
the evaluation were collected from the water tank experiment. The setup and
the equipment that was used for the experiment is shown in figure 2.10.
Figure 2.10: The diagram B shows the experiment setup. The sensor was
placed inside the applicator and It was connected to the tracking system (red
cable). The image A shows the axes directions for the experiment: X (blue), Y
(red) and Z (yellow), the origin is the centre of the transmitter.
During the experiment the sensor was attached to the platform of the wa-
ter tank phantom that allowed for a movement in three dimensions with an
accuracy of ±0.1 mm [91]. Then the platform was programmed to move the
sensor through the grid coordinates as shown in the ”Grid Scan” motion (figure
2.11) performing a 3 second stop per point as shown. The grid scan motion di-
mensions were selected based on the motion box of the sensor provided by the
58
manufacturer but increasing the dimensions in all direction to examine how
the sensor will perform and if its accuracy can be improved. The grid scan
motion was performed and captured twice, the first time the tank was empty
(air) and the second time the tank was full of water to emulate the conditions
during the insertion process.
Figure 2.11: The image A shows all the points that consist the grid scan motion.
The movement in X axes was between 5cm and 45 cm in 5 cm steps. The
movement in Y axes was between -20cm and 20 cm with 5cm steps and the
movement in Z axes was between -20cm to 20cm with 5cm steps. The motion
for each layer is shown in image B hand side image by the blue lines. The
motion was described as continuous but with a pause at each measurement
point of 3 seconds.
The sensor, as described in documentation by Ascension Technologies, has
optimum performance within the following motion box (x: 16-32cm with a
recommended maximum of 25cm, y: ± 10cm, z: ± 10cm). This should give
an RMS error of 1.4mm, -the distances are measured from the centre of the
transmitter-. During the grid scan the sensor was used to measure positions
outside the suggested motion range. The reason was to quantify how accurate
the sensor is and explore different methods of correcting any errors therefore
extending the effective range of the sensor. To be able to use the tracking
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system accurately in-vivo, the deformation field should be calibrated. A defor-
mation field is a set of deformation vectors for all the points in a 3D region of
space. The deformation vector specifies the displacement from the measured
position to the true position . During the experiment the grid scan motion was
performed and captured both in air and water. The deformation field (fd) was
estimated using the grid scan data captured in air Pa(x,y,z) and then the same
deformation field was used to correct the grid scan data captured in water
Pw(x,y,z). If the deformation field does not vary between measurements, then
the sensor can be used for in vivo applications such as tracking the applicator.
Figure 2.12 below shows the methods that were used to correct the data. Each
step of the method will be explained below.
60
Figure 2.12: Shows the methods that were used to calibrate the sensor. The
vector deformation field was estimated using the grid scan data captured in air.
Then the Deformation function was estimated. The grid scan data captured in
air were calibrated using the Deformation function. The grid scan data cap-
tured in water were also calibrated using these methods. The first method was
by applying the Deformation Function directly to the data. The second method
involved rigid registration of 8 corner points of the grid scan data captured
(both in water and in air) and then calibration using the Deformation Func-
tion. The Third method involved rigid registration between the water and the
air grid scan data, using all the measured points, and then calibration using
the Deformation Function. The registration methods aim to correct any motion
errors induced to the system between measurements.
1. Estimating the deformation field (fd): To estimate the deformation field a
suitable point from the grid was selected as the origin. The point that
was selected was at x: 176.7 mm y: -1.9mm z: 1.34mm because it was
nearest point to the transmitter that fall within the recommended range
in Ascension’s guidelines(x:16-25cm, y: ±10cm, z: ±10). Then the true
positions of the points on the grid were estimated and related to the ori-
gin position. Then the deformation vector for each point was estimated by
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subtracting the measured position from the real position using the equa-
tion below, i is the number of points f is the deformation vector,pmeasured is
the point measured by the tracking system and preal the real position of
the point.
f ideformation = P
i
measured − P ireal (2.3)
2. Eight - outer corner point registration method between water and air grid
scan data. Between measurements there is a possibility of small alter-
ations from the original position of the transmitter therefore the mea-
sured points could be different from time to time. A registration process
between a set of known points in space will improve the accuracy of the
registration be removing such an error. The eight (8) point registration
method registers the eight corner points of the motion box (x:16-25cm, y:
±10cm, z: ±10). The registration process aims to calculate the rotation
and translation between the 8-points of the real grid with the measured
grid. The algorithm that was used was a simple solid body registration.
The general solution to the problem is the following:
Ea = R ∗ Ew + L (2.4)
Were Ea is the 8-points as measured in air (to generate the deformation
matrix), R is the rotation matrix, Ew is the 8-points as measured in water
and L is the translation matrix. There are three steps involved in finding
the optimal translation and rotation, these are:
(a) Find the centroids of both datasets. The centroids are an average of
all the data points in datasets Ea and Ew.
Cair =
1
8
8∑
i=1
Eia (2.5)
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Cwater =
1
8
8∑
i=1
Eiw (2.6)
(b) Register the origin of both datasets then find the optimal rotation
(R). To remove the translation component, single value decomposition
(SVD) was used on the covariance matrix H. The SVD will decom-
pose/factorise a matrix (M), into three components matrices, such
that:
[U, S, V ] = SV D(M) (2.7)
M = USV T (2.8)
The covariance matrix H can be estimated using the equation below
H =
8∑
i=1
(Eiw − Cwater)(Eia − Cair)T (2.9)
Then by applying SVD to the covariance matrix H, the rotation can
be estimated as follows.
[U, S, V ] = SV D(H) (2.10)
R = UV T (2.11)
(c) Find the translation L. The translation can be calculated using the
following equation. Which estimated the distance from the two cen-
troids after Rotation is applied.
L = −R× Cwater + Cair (2.12)
3. Estimating the Deformation function D(x,y,z).For each point of the grid
the deformation was estimated by natural interpolation. interpolation is
a method of estimating the values of data points based on data points
63
already known. Natural Interpolation is based on Voronoi tessellation
of discrete set of data point. To be able to correct the measured points
natural interpolation was needed, the discrete set of input data points
were the measured grid data and the output values from the interpolation
were the deformation vectors. To illustrate the algorithm a 2D example will
be presented. The Voronoi regions are estimated as follow. Assume there
are n discrete control points on a Cartesian Plane B where the Euclidian
distances between points are denoted with d, each point p in plane B must
be assign a region A1 to An.
Ai = {p ∈ B|d(p,Ai) < d(p,An)} for all n 6= i (2.13)
Figure 2.13 shows how the region is assigned for an area with four (4)
control points.
Figure 2.13: Shows the Voronoi regions for 4 random points.
To Interpolate for a given point in the B plane using natural interpolation.
The Voronoi tessellation are re-estimated including the given point. Then
the weighing of each control point is given by the overlapping region of the
interpolated point and the control point normalised as shown in figure
2.14.
64
Figure 2.14: Estimation of Voronoi tessellations for a new point shown in red.
The weightings for each control point (shown in blue) are equal to the overlap-
ping region between the two points.
Then the interpolated value is given by the following equation whereDef is
the deformation at the point being evaluated, fd(xi, yi, zi) is the deformation
at the control points from 1 to i and wi denotes the weighting.
Def(x, y, z) =
n∑
i=1
wifd(xi, yi, zi) (2.14)
4. Calibration. The original position can be calculated by adding the defor-
mation vector (as calculated by the Deformation function Def(x,y,z)) at the
point of measurement.
Pcorrected = Pmeasured +Defas−measured−at−p (2.15)
2.3.5 Experiment 5: Gynaecological Phantom trial
The aim of this experiment was to evaluate the tracking methodology in the real
clinical environment using a Gynae abdominal phantom. The reason a gynae
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phantom was preferred over cadaveric vet material was due to the anatomy of
human body. The proposed methodology that was tested during the trial run
is described below. Initial Proposed methodology: In the operating Theatre:
1. Before Insertion
a. Calibration of the sensor using the 8-point calibration phantom .
b. The patient is marked using tattoo markers in three indicative position
in the abdominal area in ordered to be used as reference points for regis-
tration.
2. After Insertion
a. The sensor is to be inserted to the tandem to obtain a measurement of
the position of the sensor inside the applicator.
b. The position of the tattoo markers is also measured at the end of the
insertion process.
3. In the CT room
a. The sensor is calibrated using the 8-point phantom before insertion.
b. The position of the tattoo markers is to be measured using the tracking
system before the CT scan.
c. The sensor is inserted again in the tandem of the applicator in order to
measure the Position of the sensor inside the applicator.
d. Ball bearings are placed on top of the tattoo markers in order to provide
a reference point for the cross system registration between the CT scanner
and the electromagnetic tracking system.
The Experiment setup is shown in the figure 2.15 below. From the exper-
iment three datasets were acquired. These are the electromagnetic tracking
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system data from the operating theatre and the CT room, and the CT images of
the phantom as captured post insertion.The electromagnetic tracking system
data were then registered to the CT scanner data using SVD decomposition
as in experiment 3. Then Using the same translation matrix that was calcu-
lated by registering the three external tattoo markers to the CT ball bearings,
the electromagnetic tracking data showing the tip of the sensor inside the ap-
plicator should also be registered. The error in the position of the applicator
using the CT as the gold standard was calculated by subtracting the position of
the applicator as shown in the CT scanner and the registered electromagnetic
tracking data.
Figure 2.15: Shows the setup that was used for the trial run Experiment.
The gynae phantom outlined with red was placed underneath the transmitter
shown with blue. The same setup was used in the CT room.
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2.4 Results
2.4.1 Exmeriment 1: Software Testing and Initial Position
Measurements
The first part of the experiment involved qualitatively analysis of the developed
tracking system to achieve these two shapes were freehand traced and the
results were shown on the software in real time as show in figure 2.16. After the
analysis of the data it was observed that the shape dimensions were accurate
to up to 5 mm as shown in the table 2.4. Most of the error was likely caused by
the freehand motion. The presented data were collected using the Model 800
sensor.
Figure 2.16: Freehand Traces of the Triangle and the Trapezoid that were used
to qualitatively evaluate the software.
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Measured size (cm) Design Dimension (cm)
Triangle
Side A 11.77 11.60
Side B 10.81 11.30
Side C 10.42 10.50
Trapezium
Small Base 7.20 7.00
Large Base 13.51 13.10
Height 4.83 5.10
Table 2.4: Shows the dimensions for the shapes as measured by the freehand
motion during experiment 1.
The second part of the experiment was measuring the precision of the model
800 sensor and the effects of varying thicknesses of solid water placed in front
of the transmitter. The precision of the sensor was less than a tenth of a
millimetre for all x,y and z coordinates (x:0.01,y:0.01,z:0.00). The effects of
solid water are shown in figure2.17. As it can be seen from the graph solid
water does not affect the precision of the sensor significantly.
Figure 2.17: Shows the error caused by solid water placement in front of the
transmitter the y axis is measured in mm. Data are shown for the model 800
sensor.
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Using the model 55 sensor an experiment was performed to estimate its
accuracy as with the model 800 sensor. The model 55 precision is roughly a
tenth of a millimetre as measured using the standard deviation of the values
when the sensor was still. The deviation in values was x:0.10, y:0.11, z:0.09.
The precision measurements were taken in the middle of the motion box as
suggested from their manufacturer.
2.4.2 Experiment 2: Tracking Near Metals
Four metals were selected to study how metals affect the performance of the
tracking system those were, aluminium, brass, tungsten carbide and steel.
Aluminium and brass did not have any effect on the performance of the appli-
cator and steel is ferromagnetic therefore it causes huge errors that saturate
the output of the sensors of the electromagnetic tracker (errors > 100mm ).
The applicator contains tungsten alloy therefore the focus of the experiment
was on tungsten carbide. The experiment was done using the model 800 sen-
sor and the results can be shown in the figures 2.18 below. The model 55
sensor was directly tested with the applicator therefore and the results will be
presented in experiment 3.
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Figure 2.18: Shows the error caused by tungsten carbide when placed in each
position of the Grid as shown in experiment 2.
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2.4.3 Experiment 3: Placement of tracker inside the appli-
cator
The graph shown in figure 2.19 displays the values of x, y and z (x-height, y-
length, z-depth) axes for one of the insertions. Another interesting result from
figure 2.19 is that the distance travelled in x and y are consistent with the
known dimension of the applicator and thus provide a means to confirm that
the sensor has been placed correctly. The Model 55 sensor was used for the
experiment.
Figure 2.19: Shows values of x, y and z as a function of time for the insertion
of the sensor inside the applicator. The positional axis is in millimetres and
the time axis in tenths of a seconds. The trend in the data can be explained
by the physical dimensions of the applicator. For example, in y it is observed
that from the moment we first insert the sensor the sensor travels a distance
equal to the length of the applicator until it reaches its resting position.
The average error regarding the position of the applicator during the first
insertion is shown in figure 2.20 below along with the RMS error after the
insertion in figure 2.21. Note that during capture 6 the cable of the sensor
was shaken intentionally to test sensitivity to cable motion .
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Figure 2.20: Shows the average error for each of the sensor insertions inside
the applicator. Note that at the 6th insertion the cable was moved rapidly after
the sensor reach its resting position inside the applicator. The Y axis is in
millimetres and the X axis shows the insertion attempt. The results show that
the error is in the range of a millimetre or less.
Figure 2.21: Shows the RMS error for each of the sensor insertions inside the
applicator. Note that at the 6th insertion the cable was moved rapidly after
the sensor reach its resting position inside the applicator. The Y axes is in
millimetres and the X axes shows the insertion attempt. The results show that
the error is measurement is less than 0.5 of a millimetre.
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2.4.4 Experiment 4:Prototype Tracking System Calibration
and Evaluation
In the results, only, the points within the region of interest (ROI) are considered,
where the region of interest is defined as x = 7cm to - 27cm, y = -15cm to +
15cm and z = -15cm to +15 cm. The region of interest is where the model
55 sensor with the deformation calibration performed better than expected
therefore increasing slightly the range of the sensor where the rms errors are
less than 1.5 mm. Table 2.5 shows the estimated deformation field that was
produced using the grid scan
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Table 2.5: Shows the deformation field that was calculated using the data from
grid scan in air. The tip of the arrow shows the measured position and the point
of the arrow the real position (deformation vector). A) shows a 3D map, B) all
points observed from above, C) all points observed from the side and D) all
points observed from the front.
Table 2.6 shows the corrected positions of the measured grid scan points in
water using the first calibration method (i.e. without using a point registration).
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Table 2.6: shows the corrected position of the measured grid scan points in
water without using the 8-point registration process. The blue circles show the
position of the measured points after correction and the orange circles show
the true positions of the points. All the axes are in millimetres. A) shows a 3D
map, B) all points observed from above, C) all points observed from the side
and D) all points observed from the front.
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Figure 2.22 shows the RMS error for the above calibration. R is the mag-
nitude of the error in 3D and was calculated using the following equation:
R(ex, ey, ez)=
√
e2x + e
2
y + e
2
z. Were ex, ey and ez are the error in each of the cardi-
nal directions.
Figure 2.22: Shows the RMS error for the corrected grid scan points, in water,
using the first calibration method. In A) each vertical line splits the data into
groups of constant depth in the X direction - region 1: 70 mm, region 2 :
120mm, region 3: 170 mm, region 4: 220mm and region 5: 270mm away. B)
shows the RMS error for each of the X regions. Data are shown for X, Y, Z and
R.
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Table 2.7 shows the corrected positions of the measured grid scan points
in water using the 8-point registration process (second calibration method).
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Table 2.7: Shows the corrected position of the measured grid scan points in
water using the 8-point registration process. The blue circle shows the position
of the measured points after correction and the orange circles show the actual
position of the points. All the axes are in millimetres. . A) shows a 3D map, B)
all points observed from above, C) all points observed from the side and D) all
points observed from the front.
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Figure 2.23 shows the RMS error for the 8-point registration method.
Figure 2.23: Shows the RMS error for the corrected grid points, in water, using
the 8-corner point registration process (second calibration method). In A) each
vertical line splits the data into groups of constant depth in the X direction -
region 1: 70 mm, region 2 : 120mm, region 3: 170 mm, region 4: 220mm
and region 5: 270mm away. B) shows the RMS error for each of the X specific
regions. Data are shown for X, Y, Z and R.
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Table 2.8 shows i) the RMS error, ii) the percentages of calibrated points
with less than 1mm error, and iii) the maximum errors for all three calibration
methods. Table 2.9 shows further analysis of the 8-point registration and cal-
ibration method analysed in terms of the five regions grouped by distance in X
from the centre of the transmitter. In table 2.8, the Pa’ calibration errors are
zero because the deformation field was estimated using this data as a reference
and so the results are a consistency check of the calibration.
Table 2.8: Shows the RMS Error, the maximum Error and the percentages of
points with less than 1mm error. The total number of points in the dataset is
245. Data are shown for each of the three calibration methods used. Green
coloured values show errors < 1mm and red coloured values shows errors >
1mm.
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Table 2.9: Shows the RMS Error, the maximum Error, the percentages of points
with less than 1mm error and the percentages of points less than 1.5 mm for
each region using the 8-point registration method. The total number of points
in the dataset is 245 and each region has 49 data points. Green coloured
values show errors < 1mm and red coloured values shows errors > 1mm.
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2.4.5 Experiment 5: Gynae Phantom trial
Table 2.10 shows the results of the registration between the tracking system
and the CT scanner. The CT scanner data has resolution of 2.5mm in the x
direction, and 0.97 mm in y and z directions . The error in regards to the
positional difference of the applicator tip between the tracking system and the
CT scanner was (x,y,z) : 3.35 mm -3.12 mm -0.10mm which is inline with
what was observed in similar phantom studies using electromagnetic tracking
systems.
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Table 2.10: The registration between the electromagnetic tracking system and
the CT scanner. The blue circles shown the position of the points as they
appear in the CT scanner. The red crosses show the registered electromagnetic
tracker data from the operating theatre and the yellow crosses the registered
electromagnetic tracker data from the ct scanner room. All the axes are in
millimetres. A shows a 3D view of the registration. B shows the coronal plane.
C shows the transverse plane and D the sagittal
2.5 Discussion
The results from the experiments leading up to the trial run suggest that the
tracking system has the potential to be used in the clinical environment to
track the tip of the applicator during brachytherapy since its accuracy during
the trial run was far less than 5mm which was set as the specification for
the system. To achieve this the next stage is to measure the electromagnetic
tracking system accuracy in real life conditions, therefore a clinical trial should
be the conducted. Such a trial was setup and will be presented in the following
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chapter.
The output of the trial will be the deciding factor in the use of the electro-
magnetic tracking system in cervical brachytherapy. If the accuracy is suffi-
cient then the current brachytherapy process could change since the dosime-
try plan could be done beforehand and with the help of the electromagnetic
tracking system and the ultrasound imaging registered with an MRI image,
the applicator could be guided to the specific position without the need for a
CT scan, greatly reducing the cost and increasing the effectiveness of cervical
brachytherapy.
In addition, the methodology that was developed could be improved further
before releasing the system in the clinic, improving the overall accuracy of the
system since there are substantial uncertainties when measuring the tattoo
markers. For example, the tattoos could be replaced with surface markers or
more tracker sensors modified to be attached to markers at the patient surface.
2.6 Conclusion
The series of the experiments suggest that the electromagnetic tracking system
has the potential to track the applicator in vivo during cervical brachytherapy.
The trial run that was performed on a gynaecological phantom had a maximum
error of 3.2 mm which is within the 5mm error margin. Further clinical study
is needed to obtain an estimate of the accuracy of the tracker in the clinical
environment since a phantom is much different than a human body. Such
a study will be discussed in the following chapters. In comparison with the
previous studies using electromagnetic tracking systems the results seem to
be in line with the errors that were observed by Mehrtash et. al 2014 and
Zhou et. al 2013 [69, 70].
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Chapter 3
Clinical Evaluation of the
Electromagnetic Tracking System
3.1 Introduction
Following the work in chapter 2 an electromagnetic tracking system methodol-
ogy was developed to track the cervical applicator during brachytherapy for gy-
naechological cancer. The results from the trial run using the gynae phantom
suggested that the developed methodology could potentially be able to track
the applicator with an accuracy of 3mm. This result was quite promising con-
sidering there were displacement in the order of 1cm or more in the applicator
placement as reported by several studies. For that reason a clinical trial was
conducted with the main purpose of examining the accuracy of the tracking
system by comparing the location of the sensor inside the applicator with its
position as it appears on the CT scanner inside the applicator. CT imaging
is used in the standard brachytherapy procedure and is considered the gold
standard for measuring the applicator position relative to the anatomy of the
patient. In addition, if the accuracy of the tracking system is sufficient (<5mm
which is the current measured accuracy) the movement of the applicator (rel-
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ative to anatomy) from the operating room to the CT room will be measurable.
The trial was conducted at the Royal Surrey County Hospital. Patients treated
with cervical brachytherapy were ask to give informed consent to participate
in the trial.
The clinical evaluation methodology was designed to require minimal alter-
ation to the standardised brachytherapy procedure. The brachytherapy op-
eration was changed in the following ways in order to accommodate for data
capture during the operation (in the operating theatre and the CT room):
1. Before the applicator insertion process the patient was given standard
skin tattoos that were going to be used to provide reference points that will
be used for evaluating the accuracy of the tracking system in regards to
measurement of the position of the sensor inside the applicator relative to
these skin markers.Skin tattoos are simple indicators made with a marker
to show the position the ball bearings will be placed later on and also
be used as a reference between the electromagnetic tracking system and
the CT scanner. In addition the location those markers are placed are
in reduced movement regions to minimise the errors caused by tissue
movements. The calibration step will not be included in comparison with
the trial run since it will not be practical in the current environment.
2. The position of the markers and the tandem are to be measure at the end
of the insertion process in the operating room.
3. In the scanning room the position of the tandem and the tattoo markers
are to be measured before the patients CT scan. When the measurements
are done ball bearings are to be placed on top of the tattoo markers in or-
der to provide reference points for the registration between the CT scanner
and the electromagnetic tracking system.
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3.2 Methodology
3.2.1 Introduction
The methodology for the trial as originally proposed was changed for measure-
ments of the first patients because the results from these first patients were
found to be of limited accuracy with the gynae phantom experiment. Therefore,
the methodology was changed and tested in the subsequent data captures to
improve the overall accuracy.
The clinical trial was conducted at the RSCH and involved capturing electro-
magnetic tracking data from patients undergoing cervical brachytherapy. The
trial aimed to measure the accuracy of the tracking system by comparison with
the CT scanner, which has slice thickness of x:2.5 mm and pixel size of y: 0.9
mm and z:0.9 mm. To achieve this, the electromagnetic tracking data showing
the positions of the applicator and surface markers were collected from cervi-
cal brachytherapy procedures and the surface markers were rigidly registered
with their CT scanner positions. The applicator position was then compared
between sensor and CT scanner.
In this section the methodologies that was developed for the clinical trial
will be explained as well as discussing the differences between the initial and
final methodology that is currently in use for the trial.
In the initial method, three markers were placed on the patient surface,
close to the plane of the applicator tip and on the anterior, left lateral and right
lateral positions, see figure 3.2.
Initially the clinical evaluation of the filter followed the methodology that was
used for the gynaecological phantom experiment but without the calibration
step since it is not practical in the brachytherapy operation setup. After the
first patient the data were analysed the error that was observed was ≈10 mm
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which was not consisted with the trial experiment error of ≈3mm. It is likely
that the errors were caused in the measurement of the three body markers.
In comparison to the gynae phantom surface, human skin is moveable also
the points fall almost in a straight line in the coronal plane which limits the
registration in this axis. In addition for some larger patients, that meant the
transmitter was out of range for the model 55 sensor.
To address these issues two more points were added to enclose the applica-
tor better in three-dimensional space. The tattoo positions were also measured
using the model 800 sensor which can provide additional range and more ac-
curate measurements. Also by including more sample points the registration
error is likely to be decrease as shown in the equation below because the reg-
istration is sensitive to outliers.
RegistrationError =
i∑
1
d(P irA, P
i
B)
2 (3.1)
Where PrA is the registered matrix to the data matrix PB, d is the Euclidian
distance between the two points squared. Therefore, by having more points it
is likely to limit the effect of any outliers. The following section will explain the
methodologies and the material that were used to perform the clinical trial.
92
3.2.2 Materials
Table 3.1 shows the materials that was used for the capture and the analysis
of the clinical trial data.
Equipment
Electromagnetic Tracking System - TrackStar 3D by NDI
Applicator Set - Fletcher CT/MR by Elekta
Tracking Software - Developed in house using NDI API
CT Scanner - Lightspeed by General Electric
Matlab - Software by Mathworks
Table 3.1: Shows the equipment that was used for the clinical evaluation of
the tracking system at RSCH. A detailed description of the equipment can be
found in Chapter two under the Materials section
So far ten datasets (10) were captured for five (5) different patients. The
datasets involve two electromagnetic tracking data obtained from the operating
room and the CT room just before the patient undergo a CT scan and the
CT scan. From those datasets one was discard because the position of the
applicator had to be adjusted at the CT scanner therefore it was not used for
examining the accuracy of the applicator position and the current study.
3.2.3 Methods
Three Point Method
The first method that was used was similar to the gynae phantom experiment
but it was adapted to the clinical environment and the brachytherapy opera-
tion. The figure below shows the overview of the method.
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Figure 3.1: shows an overview of the methodology used for the clinical trial
the blue denotes steps to be taken in the operating theatre and green denotes
steps taken in the CT room.
The alterations to the steps of the general methodology for the patient scan-
ning are explained below:
1. Before the insertion process begins three tattoo markers were placed on
the patient skin anterior, left lateral and right lateral surface. These
points are illustrated in figure 3.2 below.
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Figure 3.2: Shows the position of the tattoo markers/ball bearings for the first
three point registration methodology.
2. After the insertion procedure ended the tattoo markers position and the
applicator position were measured using the electromagnetic tracking sys-
tem and the relevant software using the model 55 sensor because the
methodology aimed to use a single sensor for all the measurements.
3. After the patient is transferred to the CT scanner room and placed on
the CT the electromagnetic tracking system is used again to measure the
tattoo markers on the patient’s body using the same orientation and sen-
sors.
The dataset that was collected was then processes as it is described in the
analysis subsection.
Final Method (Five point method)
The final method was developed after the results from the first methodology
were not consistent with the previous experiments. The hypothesis was that
the model 55 sensor was out of its specified motion box and therefore it had
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increased errors in measuring position accurately. Also, the three points were
aligned in the coronal plane increasing the error values in this plane therefore.
To achieve a better methodology two extra points were introduced increasing
the coverage in the superior-inferior direction and reducing the error in the
registration. In addition, the patient’s marker tattoos were scanned using the
model 800 sensor which has greater motion box and greater sensitivity owing
to its larger size.
The alteration in regards to the original methodology steps are explained
below:
1. 1. Before the insertion process began five tattoo markers were placed on
the patient skin. Those points are illustrated in figure 3.3 below.
Figure 3.3: shows the position of the tattoo markers for the final methodology.
The blue markers are the same as in the initial methodology and the green
markers are the new additional markers.
2. After the insertion procedure ended the tattoo marker positions was mea-
sured using the model 800 sensor and the applicator position was mea-
sured using the model 55 sensor (the model 800 would be too large to fit
inside the applicator).
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3. After the patient was transferred to the CT scanner room and placed on
the CT scanner bed the electromagnetic tracking system was used again
to measure the tattoo markers on the patient’s body using the same ori-
entation and sensors.
The dataset that was collected was then processes as it is described in the
analysis subsection.
3.2.4 Analysis Methods
The aim of the data analysis was to measure the accuracy of the position of
the sensor inside the applicator in relation to the CT scanner. To do that two
approaches were used.
The first approach involved rigidly registering the marker positions as cap-
tured by the electromagnetic tracking system with the positions of the mark-
ers as appear in the CT scanner. Then using the rotation and translation
matrix determined by registering the marker positions between the two mea-
surements, the position of the sensor inside the applicator was transformed
using those matrices.
The second approach involves rigidly registering both the markers position
and the position of the sensor inside the applicator to their corresponding po-
sitions as shown in the CT scan data. In this method the sensor position is
used as an extra registration point for therefore the registration is likely to be
more accurate.
The error for both methods was calculated by comparing the registered po-
sition of the sensor inside the applicator with corresponding position of the
sensor as it appeared in the CT scan. The CT scan was used as the gold stan-
dard since its accuracy is less than a millimetre.
error = (
√
PCT − PR)2 (3.2)
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Where PCT is the position of the applicator as it appears on the CT images
and PR is the position of the registered position of the sensor inside the appli-
cator. Figure 3.4 below shows an overview of the analysis procedure.
Figure 3.4: Shows an overview of the data analysis and evaluation steps.
The analysis procedure steps are explained in more detail below:
1. The first step in the analysis process was to match the orientation axes
of the two systems. Figure 3.5 below shows the three axes as they were
originally orientated for the CT scanner and the electromagnetic track-
ing system. In addition, the electromagnetic tracking system data were
evaluated by measuring the RMS error for each of the points.
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Figure 3.5: Shows an overview of the orientation axes. On the left the axes of
the CT scanner are shown red: X axes, Y: blue axes and Z: green axes. The
corresponding matching axes for the tracking system are shown on the right.
In the tracking system the X axes translates to the Z, the Y to X and Z to Y
2. The second step was identifying the position of the sensor and the markers
on the CT images. The position of the sensor was related to the guide
wire positions that are used for treatment planning. The position that
was chosen for the markers is the nearer position to the skin in the CT
image where the marker HU is greater which signifies that the position is
near the middle of the marker. That can be seen in the figure 3.6 below.
From these data the CT position data matrix was created.
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Figure 3.6: Shows an example of how the position of each marker was defined.
On the left side is the position of the marker zoomed in the transverse plane.
The red colour shows the position that was selected to represent the tattoo
markers. The point’s position was also verified in all other planes as shown in
the right-hand side of the figure.
3. Registration and evaluation was the third and final step of the process
and involved the rigid body registration of the tracking system and the CT
scanner data. After this the agreement between the data was evaluated.
The algorithm for the process is summarised in table 3.2 below .
The dataset contains the raw electromagnetic tracking system from the
operation room (Tor) and the CT room (Tct) and the positions in the CT
scans (CTs).
1. Transform the Tor and Tct axes to match the CT scanner orientation.
{X −→ Z, Y ←→ X,Z ←→ Y }
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2. Estimate the position of the markers in the CT images and create a
matrix containing the positions of each marker (CTp).
3. Perform solid point set registration between:
Ror = Reg(Tor, CTp) and Rct = Reg(Tct, CTp) using only the marker positions
(1),(2)
Rora = Reg(Tor, CTp) and Rcta = Reg(Tct, CTp) using both marker positions
and the applicator position (3),(4)
4. Estimate the position of the applicator for (1) and (2) and then estimate
the errors by measuring the Euclidean distances between the position of
the applicator in CT and the registered datasets.
Emo = d(Ror, CTp) (1)
Emct = d(Rct, CTp) (2)
Ea = d(Rora, CTp) (3)
Eact = d(Rcta, CTp) (4)
Table 3.2: Shows an overview of the algorithm for the analysis operations.
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3.3 Results
In this section the results obtained from the (2) and (4) error results will be
presented. The reason is the operating room results will be evaluated if the ac-
curacy of the electromagnetic tracking system is sufficient because the accu-
racy of the methodology has to be determined. The figure 3.7 below shows the
applicator position error in millimetres for the three-point registration method
using the 55 model sensor (M55 ).
Figure 3.7: Shows the magnitude of the error of the applicator position in
millimetres in regarding to the CT position of the applicator using method 1.
The top graph errors were calculated using only the markers for registrations.
The bottom graph errors were calculated using the markers and the applicator
position
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Figure 3.8 shows the magnitude of error in millimetres using the model 800
sensor and the initial methodology.
Figure 3.8: Shows the magnitude of the error of the applicator position in mil-
limetres in regarding to the CT position of the applicator using initial method-
ology. The top graph errors were calculated using only the markers for regis-
trations. The bottom graph errors were calculated using the markers and the
applicator position.
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Figure 3.9 shows the magnitude of error in the sensor applicator position
in comparison with the CT position using the final methodology and the model
55 sensor .
Figure 3.9: Shows the magnitude of the error of the applicator position in mil-
limetres in regarding to the CT position of the applicator using Final method-
ology. The top graph errors were calculated using only the markers for regis-
trations. The bottom graph errors were calculated using the markers and the
applicator position
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Figure 3.10 shows the magnitude of error in the sensor applicator position
in comparison with the CT position using the final methodology and the model
800 sensor .
Figure 3.10: Shows the magnitude Error of the applicator position in millime-
tres in regarding to the CT position of the applicator using Final methodology.
The top graph errors were calculated using only the markers for registrations.
The bottom graph errors were calculated using the markers and the applicator
position.
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Figure 3.11 shows the magnitude of the error in the sensor measured appli-
cator position in comparison with the CT position comparing all four methods
derived from the three-point method and the five-point method.
Figure 3.11: Shows the magnitude Error of the applicator position in millime-
tres comparing the two methodologies and the two sensors. The top graph
shows the comparison between the two sensors for the three-point methodol-
ogy. The bottom graph shows the comparison between the two sensors for the
five-point methodology.
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Table 3.3 below shows the errors for the position of the applicator for the
three-point methodology using the model 55 and model 800 sensor.
Table 3.3: Shows a table of the errors for the applicator position in compari-
son with the CT position in millimetres for the first methodology (three-point
method) using two different sensors to measure the marker positions. X,Y and
Z show the errors in each of the axes and R is the magnitude of error.
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Table 3.4 below shows the errors for the position of the applicator for the
five-point methodology using the model 55 and model 800 sensor.
Table 3.4: Shows a table of the errors for the applicator position in comparison
with the CT position in millimetres for the final methodology (five-point method)
using two different sensors to measure the marker positions. X,Y and Z show
the errors in each of the axes and R is the magnitude of error.
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Figure 3.12: Shows the mean and standard deviation comparing the two
methodologies and the two sensors. From the results it can be seen that the
5PM methodology using the model 800 sensor is the best performing one that
can be used in real time to track the applicator. Although 5PA methodology
using the model 800 sensor has less mean error it cannot be used in real time.
3.4 Discussion and Conclusions
The aim of the clinical trial was to estimate the accuracy of the tracking system
in comparison with the CT scanner which is taken as the gold standard. At
the beginning of the trial the three-point method using the model 55 sensor
was used to evaluate the tracking system but after the first patient and the
first scan of the second patient which shown 23 mm error more options were
explored to improve the accuracy of the system.
To improve the accuracy of the system two more markers were included in
the methodology and the model 800 sensor was used to measure the position
of the markers since it can provide superior range. Therefore, a trial of the
new methodology was carried out for the scans of the fourth and fifth patients
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comparing the two methods and sensors.
From the results it is shown that overall the five-point registration method
including the applicator in the registration performed the best for both method-
ologies and both model of sensors achieving a desirable ≈ 5mm error for the
applicator position which can be consider sufficient for the placement of the
applicator. The preferred method is the 5PM which is the five point registration
method using the model 800 sensor to measure the position of the tattoos. The
position of the sensor inside the applicator is given based on the registration
of those markers therefore it can be used in real time whilst 5PA cannot. In
comparison to the tracking system developed by Xia et al. 2014 [66] which
measure external markers at the grip of the applicator at 4 fps and accuracy
of 4 mm (no bend or girth), the current system measures the position of the
applicator inside the human body with samples at 100 ms. In addition the
errors in position of the applicator as measured between fractions for several
studies [56, 57, 58, 59, 60, 61, 62, 63] were greater than 1 cm.
In conclusion a promising methodology was developed for measuring the
accuracy of the tracking system when measuring the position of the applicator
in cervical brachytherapy but more data will normalise the data and provide a
more accurate description for the accuracy of the tracking system.
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Chapter 4
The Development of a Filtering
Methodology to Reduce Metal Seed
Artefacts in Post Prostate
Brachytherapy CT scans
4.1 Introduction
In permanent prostate brachytherapy up to 150 radioactive seeds are implanted
inside the prostate gland to deliver a therapy dose to the cancerous cells.
The standard practice of evaluating the postimplant dosimetry in permanent
prostate brachytherapy is done using a 3D dataset of CT images of the prostate
gland. Figure 4.1 shows a post prostate brachytherapy CT image.
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Figure 4.1: Multiple metal artefacts present on a prostate CT image. The white
cross-like structures are the implanted radioactive seeds placed around the
prostate. The seeds are point-like and the cross-like structure is a CT recon-
struction artefact. Provided by collaborators at the Royal Surrey County Hos-
pital. It is impossible to contour the prostate, which is important for treatment
verification.
As it can be seen from figure 4.1 the radioactive seeds cause artefacts in the
images. The reason that the artefacts are cause is due to a phenomenon called
beam hardening [92, 93]. Beam hardening is caused when the lower energy
particles are absorbed by high attenuation materials such as the radioactive
seeds placed in the prostate. That causes issues with the verification of the
prostate brachytherapy which is recommended to be performed on all patients
undergoing permanent prostate brachytherapy.
The evaluation process can be described as follows [75, 76]. Firstly, a 3D
dataset of CT slices are taken covering the implanted area. Secondly, on each
CT slice, the prostate, the bladder walls and the rectum are contoured as
anatomical structures. In addition, the urethral location is estimated either
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by using ultrasound images or by using a Foley catheter. Thirdly, the data
are processed in the planning system to perform the final dosimetry calcula-
tions. Finally, the number of implanted seeds is crossed checked between the
treatment plant and the images.
The main issue with the verification procedure as described above is that
it is heavily reliant on the operator, who is responsible for outlining the rele-
vant anatomy. Due to the high number of artefacts, contouring the relevant
anatomy accurately can be a challenge. Consequently, the operator could intro-
duce uncertainties to the data and thus to the post-implant dosimetry results.
Therefore, the radioactive seed artefacts hinder the dosimetry procedure and
evaluation process.
In previous work, several researchers have developed filters for metal seed
artefacts reduction [79, 80, 94, 95, 96, 97]. Those filters can be group into
four categories: sinogram correction, iterative image reconstruction, adaptive
filtering methods and modelling based filters. The first two categories of filters
require access to the raw CT data which may be difficult and impractical to
implement in the clinical environment due to the need for direct access to the
CT scanner’s raw data. The third and fourth category can suppress the artefact
but are heavily reliant on estimating the nature of the artefact. Although these
filters can be flexible and be used in a variety of cases they are not very effective
when it comes to filtering multiple artefacts in the same image (e.g. more than
10). For example, in the post prostate brachytherapy CT scans there may be
many artefacts in a single CT slice which produces overlapping streak artefacts
and in these cases some types of filter may not be as effective.
Therefore, the aim was to filter the metal seed artefacts automatically with-
out any human intervention in the clinical environment. Therefore, the filter
would ideally not be reliant on obtaining the raw CT data or requiring an oper-
ator to identify the artefacts present in the image. In addition, the filter should
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be able to filter a dataset from a single patient in a short amount of time so as
not to hinder the work flow in the clinical environment.
In the methodology section the two main processes of the developed filtered
will be presented. Several candidate completion methods were tested. The
completion methods that were not selected for the final version of the filter will
be discussed briefly and the successful methods in greater detail.
4.2 Methodology
4.2.1 Overview
The seed artefacts consist of two components: the seed and the streak that
originate from its centre. Those components can be clearly seen in figure 4.2.
Figure 4.2: The red arrows show the bright and dark streak artefacts that
originate from the centre of the metal seed. The Blue arrow shows the seeds
as they appear in CT scans.
The aim of the filtering methodology was to filter the metal seed artefacts au-
tomatically without any human intervention in the clinical environment. Fig-
ure 4.3 presents an overview of the filtering methodology that was used to
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achieve this.
Figure 4.3: Shows the methodological overview that all the developed method-
ologies were based on. Where each algorithmic step is denoted by the arrows.
Although each filter that was developed was unique, the filtering methodol-
ogy remained the same. The filtering methodology can be described as follows.
Firstly, the image is transform to Hounsfield units. Hounsfield units can pro-
vide information about the anatomy of the structures since each material has
a distinct Hounsfield value. Secondly the HU image information was used to
segment the artefact from the image. Thirdly is the completion step being the
filtering of the metal artefactis carried out. The algorithms that were used in
each step are listed in the table 4.1 below.
The following sections will describe the algorithms used in each step-in de-
tail and outline all the methodologies that were used for filtering the artefacts
from the CT Images. The table 4.2 below presents the tools and the datasets
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Algorithm Constituents Step
Hounsfield Transformation Hounsfield Image
Manual Segmentation Artefact Segmentation
Automatic Segmentation Hough Transform Artefact Segmentation
Canny Filter Artefact Segmentation
Thresholding Artefact Segmentation
Flooding Artefact Segmentation
K-means Artefact Segmentation
Linear Interpolation Completion
Bilinear Interpolation Completion
Exemplar Image Inpainting Completion
Table 4.1: The table presents the algorithms that were developed and tested
during the filter design
that were used in the development of the filtering methodology.
Matlab Software Tool
Post prostate brachytherapy
CT Images
Dataset A
Post Breast brachytherapy
CT Images
Dataset B
Table 4.2: Shows the tools and datasets that were used in the development of
the filtering methodology.
The dataset A was kindly provided by Dr Adrian Franklin from Royal Sur-
rey County Hospital. Dataset B was kindly provided to Professor Evans by
Matthieu Bal to be used to compare the results of the develop filter with their
methodology.
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4.3 Algorithms
4.3.1 Hounsfield Transformation
The first step of the filtering methodology remains the same for all the developed
filters and it involves transformation of the pixel values of the CT image scan
into Hounsfield Units (HU). HU can be used to determine the type of tissue that
is present in the image. The HU calibration is contained within the DICOM
header of the image. DICOM is a file format that is used for medical data and
it is agreed upon by several healthcare manufacturers.Therefore, transforming
the pixel values to HU can be done using the following equation:
IHU = (Io ×RescaleS) +RescaleI (4.1)
Where IHU is the Image in Hounsfield units, Io is the original image, rescale
slope (RescaleS) and rescale intercept (RescaleS) are constants determined by the
manufacturer of the CT scanner for transforming IHU to integers and vice versa.
Those can be found in the DICOM file header (Rescale intercept, (0028—1052),
and rescale slope (0028—1053)).
Artefact Segmentation Methods
The aim of the artefact segmentation method is to segment the streaks and the
metal seed artefact to be used in the completion step. In other words to identify
the region where the artefact is and then used a method that could estimate
what the image could look like without the artefact. Figure 4.4 below shows
an overview of the artefact segmentation methodology.
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Figure 4.4: Shows the two components necessary to segment the Artefact from
the Unfiltered Image.
Two main methodologies were developed for segmenting the artefact from
the image those are the manual and the automatic method. The manual
method is based on the user ability to identify and select the metal seed and
the streaks. On the other hand, the automatic method aims to segment both
the metal seed and the streaks automatically.
4.3.2 Manual Segmentation Method
In the manual segmentation method, the user is given a copy of the original
image. Then the user proceeds in selecting the metal seed artefacts and the
streaks using the red colour marker as shown in figure 4.5 below.
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Figure 4.5: Manual Segmentation. Shows the manual segmentation processes.
The image A is the original image and Image B is the manually segmented
image.The red marked area will be estimated by one of the completion methods
4.3.3 Automatic Segmentation Methods
Thresholding
Thresholding can be used to identify markers on the HU image (IHU ). Since the
HU value for the metal artefacts was found to be very high at around 5500 HU,
by performing the following conditional statement 4.2 we can obtain the metal
seeds and add them to the metal seed mask Mmask. The metal seed mask is a
binary matrix that has the same size as the original image where the numeral
ones indicated the location of the metal seed.
IfIHU(p) > 5500, thenMmask = 1∀p (4.2)
The thresholding algorithm can be performed following the steps showing
in the table below.
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1. Initialise Mmask matrix to the same dimensions as the image and set
its cells to zero. Mmask = 0;
2. Check each cell (p) of the IHU using the following condition
If IHU(p) > 5500, thenMmask(p) = 1;
Table 4.3: Thresholding Algorithm for metal seed identification.
K-means Segmentation
The k-means algorithm aims to segment the image (IHU ) into groups called bins
(Bin) based on a set of initially predefined centroids (C - mean values). Cen-
troids (C) are equal to the mean value of the elements that belong to the corre-
sponding bin . The mean values (C) and the Bins (Bin) are determined based
on the HU values of the following:, air (Ca = -1000HU), urine (Ctl = 15HU), soft
tissue (Cth = 120HU), bone (Cb = 700 HU) and metal (Cm= 5500HU). Then for
each pixel of IHU the Euclidean distance (d) was estimated between the IHU(p)
and each centroid value. The difference was calculated using the following
equation 4.3.
d(IHU(p), C) = |p− C|∀C (4.3)
The IHU(p) is then added to a bin (Bin) which had the minimum distance (d)
from its corresponding centroid (C). A new set of centroids (nC) were estimated
by calculating the mean of each bin (Bin). The new centroids were calculated
using the following equation 4.4.
nC(i) =
1
j
j∑
j=1
B(j),∀j ∈ Binand∀i ∈ nC (4.4)
The algorithm was iterated until the new set of Centroids (nC) were equal
to the previous set of centroids (C). That indicates that the algorithm has
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converged improving the segmentation of each region. The k-means clustering
was performed following the following algorithm in table 4.4.
1. Initialise the centroids C Ca, CtL, CtH , Cb, Cm
2. For each IHU (p), Estimate Bins Bina, BintL, BintH , Binb, Binm =
min{d(IHU(p), C)}
3. Estimate the new Centroids nC nCa, nCtL, nCtH , nCb, nCm = 1j
∑n
n=1Bin
where n is the number of elements that belong to Bin.
4. If (C = nC) Done, else nC = C and repeat steps 2,3 until Done.
Table 4.4: K-means Segmentation Algorithm.
4.3.4 Streak Segmentation Methods
Canny Edge Filter
The Canny edge filter [98] was used to identify the edges of the IHU . An edge in
the image is a transition between intensities. The streaks transition from high
intensity to low intensity then to high intensity as shown in figure 4.6 therefore
that makes the streaks identifiable using an edge detection filter.
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Figure 4.6: Metal Seed Artefacts. The red arrows show the bright and dark
streak artefacts were the transition between bright and dark regions are iden-
tifiable. That originate from the centre of the metal seed shown with a Blue
arrow.
This property of the streaks ensures that they will be identifiable using an
edge detector. A Canny edge detector was used because of its advantages in
localising the centre of the edge that is only marked once in comparison with
other edge detection techniques [99]. For this Function the standard MATLAB
function was used.
Hough Transform
Hough transform is a feature extraction method that can be used to identify
straight line in images. The Hough transform is performed on the detected edge
of the IHU . To detect the lines in the image multiple lines are drawn for each
edge point in the following form r = x cos θ+ y sin θ, where r is the perpendicular
distance from the origin of the matrix to the drawn line. Then for each point the
r and θ are drawn. The process is repeated until there are no more points left.
The lines are identified where the curves are intersecting creating a maxima.
That was done using the MATLAB functions Hough and Hough lines.
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Heuristic Methods
Flooding
The final step of the segmentation is obtaining the mask of the artefact. That
was achieved by a heuristic process called flooding. The method was based
on observations made from post brachytherapy prostate CT images. As it was
observed some of the metal seeds (usually the dimmer seeds) had similar HU
to bone. Therefore they were wrongly identified as bone. To correct that all the
bone structures in the image segmented image with less than ninety (90) pixels
were added to a test subgroup (Ts). That decision was made because it was the
maximum number of pixels that a metal seed could consist of. Then for each
substructure the minimum Euclidean distance (d) to bone and metal structures
was found. The test structure was added to the bin that it was nearest to.
To segment the streaks (Str) the edges nearest to the metal structures were
found and added to the artefact mask (Amask) along with the metal segment
(Binm). Then an iterative process called ”flooding” was performed to identify
and segment the artefact. For each of the individual streak. For each pixel
currently in Amask(p) the nearest neighbour’s pixel Intensity was checked. If the
intensity of those pixels falls within the top 5% of Binth region and the lowest
5% of the BintL region was marked as a part of the artefact. Then the process
was repeated for all the newly added pixels until the artefact was completely
segmented. The process for the artefact segmentation is shown in table 4.5 .
4.3.5 Completion Methods
In the following section the completion methods shown in table 4.6 will be
presented. All the methods will be briefly explained except the exemplar-based
image inpainting which was the method in the developed filter.
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1. Create a test subgroup Ts = Binb(e) ≤ 90 .
2. Add Ts to Binb or Binm based on the nearest, min{d(Ts, Bb)} and
min{d(Ts, Bb)}
3. Mark nearest streak S based on min{d(Str, Bm)}.
4. Add Bm and Str to Amask(p).
5. The maximum threshold, maxT = max(Bth) - ( (max(Bth) - min(Bth) ) ×
0.05) and the minimum threshold, minT = min(Btl) + ( (max(Btl) ±min(Btl)
) × 0.05), + if min(Bth) < 0, − if min(Btl) ≥ 0.
6. For each pixel Amask(p) with coordinates p(i,j) check nearest pixels
p(i+1,j), intensities (L) . If ( L > maxT | L < minT) add p(i,j) to Amask.
7. Repeat step 6 until all the artefact pixels are added.
Table 4.5: The flooding process which is an optimisation process that improves
the automatic segmentation of the artefact.
1.Interpolation Methods .
2.Exemplar-Based Image Inpainting.
Table 4.6: Completion methods that were used during the development of the
filter methodology.
Interpolation Methods
The Interpolation completion methods were used both in the sinogram space
and image space. Sinogram is a representation of integral along a projection
path.To use interpolation in sinogram space both the metal artefact mask and
the original image were transformed to sinograms using Radon transform. The
interpolation completion method was then applied to the masked region of
the sinogram that was deduced from the metal artefact mask. The completed
sinogram was then transformed to the artefact free image using inverse radon
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transform. The interpolation methods that were tested are the following:
1. Method One: Linear Interpolation was performed in the displacement
axes (horizontal Direction). The interpolation equation between two points
A(x(0),y(0)) and B(x(1),y(1)) was given by y−y0x−x0 =
y1−y0
x1−x0 was then solving for y
the equation is obtained. The above equation was obtained geometrically
by finding the equation of a straight line between point A and B. Then
the unknown value M was calculated. A representation of the geometry
is shown in figure 4.7 .
2. Method Two : Bilinear Interpolation. For calculating the value of a masked
pixel M(xm,ym) the nearest four points were found A(xA,yA), B(xB,yB), C(xC,yC),
D(xD,yD) as shown in figure 4.7 . For each point the distance (d) was cal-
culated for point A. The distance was given by
√
(xm − xA)2 + (ym− yA)2.
Then a weighting (w) was determined for each point, since four points were
used the weighting was calculated by wA = 0.25dA . The normalisation factor
(N) then was equal to
∑
wi were i is the number of points. Finally the
value for the point M was given by M = A×wA
N
+ B×wB
N
+ C×wC
N
+ D×wD
N
3. Method Three : Third order Polynomial Interpolation. This method has
similarities with linear interpolation but instead of finding the equation
of straight line between the points a third order polynomial with general
equation y = ax3 + bx2 + cx + d was estimated. This requires a minimum
of four points as shown in figure 4.7. Then by solving systems equations
the coefficients of the equation were obtained. Then the intensity of the
masked pixel at position x was obtained by solving the equation for y .
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Figure 4.7: Interpolation methods. The M pixel has an unknown value. The
A,B,C and D pixel values are known. In each case different interpolation meth-
ods were used to estimate the value of M.
Exemplar Image Inpainting
The algorithm that was developed is based on ”Region Filling and Object Re-
moval by Exemplar-Based Image inpainting” by Criminisi et al. 2004 [87]. The
algorithms fill the artefact region that was marked from the segmentation step
with information based on the present image. The image is split to two parts,
the source region and the fill region. The outline of the fill region is found and
then the filled region is completed using information from the source region of
the image. An overview of the method is shown in figure 4.8.
126
Image A shows the original image
with the region to fill (Rf ) which is
shown as a white square with a black
outline (dW ). In this step the priority
term (P) is calculated for each point of
the outline.
Image B shows the point of the outline
with the highest priority with a red
colour and a red contour which
represents the preselected patch size
(Wp). Then the image is scanned and
compared with other regions of the
image until the sum of square
differences (SSD) between the
compared patches is minimum. In this
case the purple patch was selected as
the best candidate(Wm).
Image C. After the purple patch was
found the missing patch information
of the red patch was filled using the
pixel values of the purple patch. Then
the new outline was re-evaluated and
the same process is repeated until the
image has no more blank spots.
Figure 4.8: Overview of the Exemplar image inpainting method.
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In a nutshell the algorithm aims to fill the filled region by replacing the
missing information with the most suitable information from the same image
prioritising the preservation of the edges. The order that the filled region is
completed is based on the priority term (P) which is calculated for each outline
point. The priority term is calculated using the following equation 4.5:
P (p) = C(p)D(p) (4.5)
Where C(p) and D(p) are the confidence term and data term respectively.
The confidence term C(p) presents the percentage of the patch with known
information and the D(p) term represents strong edges. Those terms can be
calculated using the following equations:
For the Confidence term (C):
C(p) =
1
|W |
q∑
1
Rs(q) where q ∈ W ∩Rs−Rf (4.6)
Where W is the size of the selected patch, Rs the source region and Rf the
region to fill.
For the Data term (D):
D(p) =
|∇I⊥p · np|
a
(4.7)
Where ∇I⊥p is the isophote direction and intensity, np is the unit vector orthog-
onal to point p and a is the normalisation factor for the image. In the current
implementation of the filter a is set to 1 since a normalised version of the image
is used.
When the priorities are calculated the outline point with the maximum pri-
ority is selected for completion. Then each for each patch of the same size from
the source region the sum of squared differences is calculated for each patch.
Then the patch that has the minimum difference is selected to fill the remain-
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ing pixels of the selected patch. The image is then updated and the confidence
terms are recalculated for the next iteration. The table 4.7 below provides an
overview of the algorithm.
1.Set the size of the patch W.
Repeat the following steps until there the region to be filled (Rf ) is com-
pleted.
2.Find the outline dW of the Rf region
3.Compute the priority P for each pixel of dW
4.Select the highest priority patch (Wp) and find a patch (Wm) that min-
imises the SSD (Wp,Wm).
5.Copy the missing image information from Wm to Wp.
6.Update the C(p) for each new pixel position on the new dW .
Table 4.7: Exemplar image inpaint completion method algorithmic steps.
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4.3.6 Filtering Methodology
Using the aforementioned algorithms several methodologies were developed
and tested following the methodological overview which consists of the seg-
mentation of the artefact followed by a completion method. Those methods
can be seen in the table below.
Methodology
Name
Artefact Segmentation Methods Completion
Methods
Sinogram In-
terpolation
Filter
Thresholding Interpolation
Methods
Hough Trans-
form Filter
K-means Algo-
rithm
Hough Trans-
form
Flooding Interpolation
Methods
Exemplar Im-
age Inpainting
Filter
K-means Algo-
rithm
Canny Edge
Detection
Flooding Exemplar Im-
age Inpainting
Manual Seg-
mentation
Exemplar Im-
age Inpainting
Table 4.8: Presents the filtering methodologies that were tested during the
duration of the research.
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Sinogram Interpolation Filter
The figure 4.9 below shows the methodology of the sinogram interpolation filter.
Figure 4.9: The figure shows the methodology that was developed for filtering
the metal artefacts.The arrows represent different operations. Blue is transfor-
mation from pixel intensity values to Hounsfield Units. Purple is the applica-
tion of a Gaussian filter with sigma = 2. Orange is the segmentation operation.
Green is Radon transform. Yellow declares the completion operation. Finally,
the red is the inverse Radon transform operation.
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Hough Transform Interpolation Filter
The figure 4.10 shows the methodology that was used for the Hough Transform
Interpolation filter.
Figure 4.10: The figure shows the methodology that was developed for filtering
the metal artefacts. The arrows represent different operations. Blue is trans-
formation from pixel intensity values to Hounsfield Units. The orange arrow
represents the k-means segmentation algorithm. The yellow arrow represents
the canny filter which is necessary for the Hough transform which is shown
by the green arrow. Then The flooding operation shown by the purple arrow.
Then the image is completed using the interpolation methods or diffusion (red
arrow).
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Exemplar Image Inpainting Filter
The figure 4.11 shows the methodology that was used for the Hough Transform
Interpolation filter.
Figure 4.11: The figure shows the methodology that was developed for filtering
the metal artefacts. The arrows represent different operations. Blue is trans-
formation from pixel intensity values to Hounsfield Units. The orange arrow
represents the k-means segmentation algorithm. The yellow arrow represents
the canny filter which is necessary to find identify the edges. Then The flooding
operation segments the artefact and its shown by the purple arrow. Then the
image is completed using exemplar image inpainting (red arrow).
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As seen from the result comparison between the state of the art method
(Bal & Spies 2006[79]) the final filter methodology both methods improve the
image quality significantly. From the images in table 4.9 and 4.11 it can be
observed that the Bal & Spies method in some cases has residual streaks that
remain (images 5,6,7) lowering the image quality and in the image and in some
cases the seed and streaks are not as bright (images 1 ,9, 13). In contrast the
final filter did well in removing the streak artefacts and the seeds but in some
cases, it suffered from ”blocking” meaning due to the lack of information the
same structure propagated in the filling region (image 7).
The final filtering methodology has both the advantage and the disadvan-
tage of preserving edges. An advantage because although the information in
the image is lost by preserving the edges some tasks like contouring of the
prostate could be improve. It could also be a drawback in case the artefact is
not segmented properly because the streaks are classified as edges by the algo-
rithm. An example of these can be seen using the automatic segmentation in
image 6 in table 4.10. That is also the reason the manual segmentation of the
artefact has better results in comparison to the automatic method. Another
drawback of the filter is when the artefacts overwhelm most of the image such
as in image 4 in table 4.10 reducing the amount of information the completion
algorithm can use to complete the image some of the artefact remains. Con-
sequently, there is a higher probability of the region to be completed using the
wrong information such as bone structures etc.
Although the automatic segmentation method is not as effective as the man-
ual method - as it can be seen from the profiles in row two of 4.11 - it can be
easily added to the post prostate brachytherapy verification routine if the qual-
ity of the images does improve since it takes minimal time and effort to filter
the images. The time for automatic filtering a full dataset of post prostate CT
images is under 10 minutes using a regular computer utilising four proces-
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sor cores which means that it can be used in the clinical environment without
disturbing the workflow for the verification process.
4.5 Discussion
The results show the developed methodology to have achieved the desired goal
of reducing the severity of the artefacts from the implanted seeds or to remove
them completely in some cases. As a result it was decided that this method
could be used for the study described in the next chapter.
Currently the manual artefact segmentation method results are superior
to the automatic segmentation method. Therefore, improving the artefact seg-
mentation method could be beneficial for the image quality. That could possi-
bly be done by exploring the possibilities of using machine learning to segment
metal seed artefact from post prostate CT images. In addition, the flooding al-
gorithm could be improved by calculating the directionality of the streak thus
improving the quality of the artefact segmentation.
In the cases of large artefacts like in images 2,4,5,6 in table 4.10 that can
cause blocking or adequate image quality it could be possible to use previous
slices as an information sources to complete them consequently improving the
image quality.Finally, the use of exemplar image inpainting in sinogram space
is also worth exploring.
4.6 Conclusion
In conclusion the final filter methodology that was developed is an effective way
of filtering metal seeds from post prostate CT scans fast and efficient as it can
be seen from the results. Both the automatic segmentation and the manual
segmentation can be used in the clinical environment to improve the diametric
plan.
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Chapter 5
Evaluation of Filter for Post
Prostate Brachytherapy CT Images
5.1 Overview
Following chapter 4 a filter was developed to filter post prostate brachyther-
apy images from the artefacts that occurred due to the placement of the ra-
dioactive seeds in the prostate gland. The aim of the filter is to remove the
artefact caused by the radioactive seeds allowing the clinicians and the radio-
graphers to improve the accuracy of the prostate contours in the post prostate
brachytherapy images. Those images are used for evaluating the dose that
was delivered by performing prostate brachytherapy therefore having accurate
contours of the prostate will improve the evaluation of the treatment. The cur-
rent standard practises involve contouring the prostate in images packed with
artefacts therefore the contour of the prostates is usually overestimated. In
order to examine the effectiveness of the filter a clinical study was developed
and contacted with our collaborators in Surrey Royal County Hospital.
The aim of the study is to measure the inter-observer reliability of contouring
the prostate in filtered post prostate brachytherapy CT images using the man-
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ual methodology as described in the previous chapter and unfiltered versions
of those images.The following chapter will explain in further detail the method-
ology for the study, results from the filtered images and discussion about their
significance.
5.2 Methodology
5.2.1 Overview
The aim of the trial is to serve as a preliminary study to evaluate if filtering the
artefacts from post prostate brachytherapy CT scans could potentially improve
the contouring of the prostate improving the verification of prostate brachyther-
apy. The trial was a collaboration with the Royal Surrey County Hospital. The
trial involves measuring the inter-observer reliability between the prostate con-
tours in filtered and unfiltered post prostate brachytherapy CT images.Two ob-
servers (A and B) with several years of experience in contouring post prostate
CT images were involved in this study. The observers were asked to contour
the prostate in filtered and unfiltered images separately. Then the contours
were compared and the reliability was measured using the Jaccard similarity
coefficient which measures similarity in finite sample sets. In the filtered im-
ages it was decided to remove the seeds from the image to ensure that there is
no bias in the contours since some of the methods of contouring the prostate
involve to some extend contouring around the implanted seeds.
In this section the materials,the methods and the preliminary results that
were used for this study will be presented and discussed.
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5.2.2 Materials
Patient Data
For the trial, eleven (11) patient datasets were provided from our collaborators
at Royal Surrey County Hospital (RSCH).Each of the datasets feature 51 CT
slices from post prostate CT scans and a single DICOM-RT file that contains
the contours of the prostate. Those dataset were filtered and provided back to
our collaborators.
Matlab
Matlab was used for the filtering and the analysis of the data.A part of the data
pre-processing was done using CERR (Computational Environment for Radi-
ological Research) which is a Matlab based software platform for radiological
research.
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5.2.3 Methods
An overview of the methodology is shown in the figure 5.1 below.
Figure 5.1: Shows an overview of the methodology that was used to analyse
the filtered and unfiltered image prostate contours. A, B and C denote parts of
the data analysis that will be explained below
The analysis of the data is done in three steps (A,B,C). Those steps are the
following an :
Step A. The prostate contours drawn by observer A and B in the filtered and
unfiltered images are loaded in CERR and then using the built in functions of
union and intersections two new contours are drawn for the A ∩ B and A ∪ B
as shown in figure 5.2. That will create and save two new contours that can
be loaded to matlab for further analysis.
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Figure 5.2: Shows images of the contours created using the CERR software.
Image A shows the contours of observer A (Blue) and B (Purple) on a filtered
post prostate CT image. Image B shows the new contour for A ∪ B (Brown).
Image C shows the new contour for A ∩B (Green)
.
Step B. The contours of A∪B and A∩B for each CT image were loaded into
matlab for futher analysis. In matlab the regions for each contours were esti-
mated using the number of pixels/voxels enclosed in the region. Since there
are no means to determine the actual position of the prostate A∪B was used as
a reference for the position of the prostate while A∩B is the region where both
observers agree is prostate. Therefore to estimate the inter-observer reliability
the Jaccard similarity coefficient (J) was used. The Jaccard similarity coeffi-
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cient is used to measure the similarity between the two volumes as shown in
the equation below.
J =
Vsize ×
∑n
1 (A ∩B)
Vsize ×
∑n
1 (A ∪B)
=
∑n
1 (A ∩B)∑n
1 (A ∪B)
(5.1)
Where A,B are the contours drawn by the observers, Vsize is the volume of
the Voxels,and n the number of slices. The result of the equation indicates
the similarity between the two volumes ranging between 0 and 1 where 1 is a
perfect match.
Step C. Estimating the average similarity per slice. The average similarity
per slice Js was estimated using the following equation.
Js =
1
n
n∑
1
A ∩B
A ∪B (5.2)
where A,B are the contours as drawn by the observers Js is the average
similarity per CT slice, n the number of slices.
5.3 Results
From the filtered images that were provided back to the observers from con-
touring only patient one and patient two were available for analysis.
Patient 1
The figure 5.3 below shows the similarity between the observer A and observer
B for the contours in the unfiltered and filtered images.
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Figure 5.3: Shows the similarity between the contours drawn from observer A
and observer B in filtered and unfiltered images
.
The figure 5.4 below shows the volume similarity between the observer A
and observer B contours for the filtered CT scans of patient one.
Figure 5.4: Shows the volume similarity between the contours drawn from
observer A and B for patient 1 in filtered and unfiltered CT images
.
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Patient 2
The figure 5.5 below shows the similarity between the observer A and observer
B for the contours in the unfiltered and filtered images.
Figure 5.5: Shows the similarity between the contours drawn from observer A
and observer B in filtered and unfiltered images
.
The figure 5.6 below shows the volume similarity between the observer A
and observer B contours for the filtered CT scans of patient two.
Figure 5.6: Shows the volume similarity between the contours drawn from
observer A and B for patient 2 in filtered and unfiltered CT images
.
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From the results it is difficult to determine if the filter improves the contour-
ing of the prostate observed since the data provided to date from both observers
are only for the filtered images. In patient one the similarity between the vol-
ume is better for the unfiltered images but in the second patient the volume
similarity is better in filtered images. The similarity of 75% percent between
observer A and B in filtered images for patient 1 and 2 could be considered
inadequate but more data are needed to be certain since the contouring of the
prostate is very reliant on the radiologist.
5.4 Discussion and Conclusions
From the preliminary results of the trial the inter-observer reliability of the
contours was measured to be 75% for the filtered images. There is a lack of
data at the moment to make a direct comparison with the unfiltered images but
assuming that the measurement of reliability between the contours of observer
A for patient 1 the similarity was measured at 83% and it seems the filtering
does not significantly improve the accuracy of the contouring. In a study by De
Brabandere et al. [77] which measured the interobserver variability in contours
of 8 physicians showed 23% mean variation between the contoured volume and
the reference volume for 3 patients.
In addition the 83% volume similarity to the reference volume that was ob-
served for patient 1 at two different points is in line with what was observed in
previous studies. That shows the severity of the problem since an experienced
observer was not able to achieve higher similarity to the magnitude of 95% with
the current techniques.
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Chapter 6
Discussion,Conclusion and Future
Work
6.1 Overview
In this final chapter the key results and conclusion of the work that was pre-
sented will be discussed. Also a proposed guideline for future work is presented
for further development for evaluation of the electromagnetic tracking system
for gynecological applicators during cervical brachytherapy and for improving
the filtering methodology for post prostate brachytherapy CT images.
6.2 Electromagnetic Tracking System for Cervical
Brachytherapy
At the moment the clinical trial of the electromagnetic tracking system is still
on going to establish an accurate measurement of the accuracy of the system
in comparison with the CT scanner which has accuracy of better than a 1mm.
The average magnitude of error for the position of the sensor inside the applica-
tor using the five-point methodology is currently ≈5mm. In the trial run using
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the three-point methodology the error was≈3mm. The difference in magnitude
of error suggest that there is an increase error measuring the tattoo marker
positions in the patients due to the elasticity of the skin reducing the quality of
the registration. The accuracy of ≈5mm would already be an improvement to
the existing methodology since the reported displacement errors for the posi-
tion of the applicators are more than 1cm [56, 57, 58, 59, 60, 61, 62, 63]. With
more work and implementation in the clinical environment could potentially
reduce the perforations and the complications due to the misplacement of the
applicator. Likely improvements to the current method will be presented and
discussed in the future work section.
6.3 Filter for Post Prostate Brachytherapy CT scans
A filter was develop for filtering seeds from post prostate CT using inpainting
methods that aimed to assist with the contouring of the prostate. In compar-
ison with the Bal et at. method in the breast images the results qualitatively
look very similar[79]. In post prostate CT images with larger count of seeds the
filter performed well removing the majority of the artefact but in some cases it
created a new type of blocking artefact that is caused by completing the image
with a less optimal image block causing a propagation of the error. Usually this
phenomenon is caused in images with less information (artefacts dominate the
image).
Therefore to estimate the usefulness of the filter a clinical study was setup
to measure the inter-observer reliability of the prostate contour in filter post
prostate brachytherapy CT images and compare that with the reliability of the
prostate contour in unfiltered post prostate brachytherapy CT. At the moment
the study is on going and there are data only for the first two patient datasets
of filtered post prostate brachytherapy CT scans. The reliability was measured
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to be 75% between the two observers for those datasets this is comparable
to studies that report similar outcomes for prostate contours. For example
De Brabandere et al. observe a mean variation of 23% between the reverence
volume and the contoured volume of 8 observers [77]. That shows the filtering
did not improve the reliability of the contouring but more data are needed in
order to make a fair comparison.
6.4 Conclusions
1. A electromagnetic tracking system was developed for tracking gynecolog-
ical applicator during cervical brachytherapy.
2. The electromagnetic tracking system accuracy of ≈5mm produced by the
final methodology is a an encouraging indicator that the electromagnetic
system could provide the means to track the applicator in vivo during the
applicator insertion process and likely be able to detect any movement
that happens until the patient is connected to the after-loading system.
3. A filter was develop for filtering seeds from post prostate CT using exem-
plar image inpainting for completion. The filter features a fully automatic
method of operation and a manual operation method. The purpose of the
automatic method is to reduce the load of the clinicians and be used in
the clinical environment.
4. Preliminary results from the filter study show reliability of be 75% between
the two observers, which does not seem to improve the contouring of the
prostate but more data are needed in order to do a direct comparison with
the unfiltered data.
159
6.5 Future Work
For the further development of the electromagnetic tracking system.
1. Continue the data acquisition from patients that undergo cervical brachyther-
apy in order to increase the confidence level of the results and obtain a
more accurate evaluation of the accuracy of the tracking system in com-
parison to the CT scanner accuracy.
2. If the accuracy of the tracking system is measured to be within a 5mm
error margin, then a comparison can be done with the measured operating
room position of the applicator and the CT position of the applicator and
deduce if there is significant movement between when the patient is moved
from one room to another.
3. Develop a robust way of using the tracking system in the operating room
and the CT room to minimize the error of capturing and tracking the
position of the tattoo markers placed on the patient during the insertion
process. That could potentially be done by introducing more sensors or
by having cameras to motion track the marker positions.
4. Explore the possibilities of using MRI or CT registered with the ultrasound
images and the applicator during the insersion process to better track the
applicator and also providing more information to the user in regard to the
patients anatomy. That could be done by using the markers as reference
points throughout the whole process.
5. Propose new ways of performing brachytherapy planning based on a pre-
treatment scan of the patient with a set position for applicator.
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For the further development of the post prostate brachytherapy CT scan
filter:
1. Continue the clinical evaluation of the filter.
2. If the cross observer reliability deemed poor. The filter is likely to improved
by using previous filtered image slices as well for the exemplar image in-
painting techinque since the image distortion is a product of low residual
information in the image.
3. If the cross observer reliability is better in the filter images a study should
be conducted to measure quantitatively the volume of the prostate that
was contour in filtered and unfiltered CT images in comparison with an
MRI that should be performed the same day as the post prostate CT scans.
4. Machine learning could potentially be used to provide an alternative way
of segmenting the artefacts from the image and could be likely be used as
a completion method.
5. Suggest a new standard practice for performing evaluation of the prostate
brachytherapy procedure if the filtering process improve the reliability of
contouring the prostate.
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